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Skin is the largest organ of the our body, and wound healing is an issue of some critical concern. 
This study aims to fabricate scaffolds to facilitate wound healing. The major extracellular matrix  
(ECM) components, including collagen, elastin, glycosaminoglycans (GAGs, including hyaluronic 
acid), and GAG-like marine polysaccharides-ulvan, were explored here to mimic the compositional 
property of natural skin. Electrocompaction, which is a technique used to fabricate densely packed 
and highly ordered collagen structures, was utilized in this research to mimic the structural property 
of natural skin ECM. It is worth noting that, the work described in this thesis is the first example of 
utilizing the technique of electrocompaction in the area of skin regeneration.  
To test the feasibility of collagen electrocompaction and evaluate its ability to support skin 
regeneration, two types of skin scaffolds were fabricated and evaluated. In the first study, a 
collagen/sulfated xylorhamnoglycuronan (SXRGlu) scaffold was built. The fabricated 
electrocompacted collagen/SXRGlu matrices (ECLCU) were characterized in terms of 
micromorphology, mechanical property, water uptake, and degradability. The viability, 
proliferation, and morphology of human dermal fibroblasts (HDFs) cells on the fabricated structures 
were also evaluated. The results indicated that the electrocompaction process could promote 
structures that support HDFs proliferation, and the introduce of SXRGlu improves the water uptake 
ability and improves stability against collagenase degradation, also supporting fibroblast spreading. 
Therefore, all these results suggest that the electrocompacted collagen/SXRGlu scaffold is a 
potential candidate as a dermal substitute with enhanced biostability and biocompatibility.   
Then, to better mimic the compositional property of natural skin ECM, an ECM-like scaffold 
comprising the structural protein collagen I (COL) and elastin (ELN), and glycosaminoglycans 
(GAGs) hyaluronan (HA) were fabricated and evaluated. Specifically, collagen and elastin were 
electrochemically aligned to mimic the morphological and mechanical properties of the dermal 
matrix. HA was incorporated into the electrocompacted collagen-elastin (CE) matrices via physical 
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adsorption and chemical linking, to achieve a final composition of 7:2:1 between collagen, elastin, 
and HA. This produced a final collagen/elastin/hyaluronic acid scaffold (CEH) that recapitulated 
compositional characteristics of the native skin ECM. In this research, we analyzed the effect of 
CEH composition on the cultivation of human dermal fibroblast cells (HDFs) and immortalized 
human keratinocytes (HaCaTs). We showed that the CEH scaffold supported dermal regeneration 
by promoting HDFs proliferation, ECM deposition, and differentiation into myofibroblasts. The 
CEH scaffold also supported epidermis growth by supporting HaCaT proliferation, differentiation, 
stratification. A double-layered epidermal-dermal skin structure was also constructed on the CEH 
scaffold supporting its ability to promote skin cell function and skin regeneration. 
Taken together, ECM-like skin scaffolds that mimic the compositional and structural characteristics 
of natural skin ECM were fabricated and evaluated in this thesis. The results confirmed the 
feasibility of utilizing the method of electrocompaction for skin scaffold fabrication. The fabricated 
skin scaffolds, especially the ECM-like CEH scaffold, may serve as a promising candidate for skin 
regeneration and wound healing application. 
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1.1 Human skin structure and function 
Skin is the largest organ in the human body and acts as a physical barrier against the 
external environment, such as chemicals, UV-radiation, temperature, and pathogens [1]. 
Human skin is made up of three main layers (Figure 1.1): the epidermis, dermis, and 
hypodermis or subcutaneous [1].  
 
Figure 1.1. Human skin structure. 
The epidermis contains mainly keratinocytes, which acts as the first barrier against harmful 
pathogens and environmental hazards. Underneath the epidermal region is the dermis, 
which is predominantly extracellular matrix with fibroblasts. The dermis can be 
categorized into two layers, an upper papillary dermal layer and a lower reticular dermal 
layer [2]. The ECM of the papillary dermis is mainly composed of thin, randomly oriented 
collagen fibers. The reticular dermis comprises type I collagen fibers that are thick and 
highly organized, and elastic fibers produced by dermal fibroblasts. Dermis houses nerves, 
blood vessels, and vital ECM components such as collagen, elastin, and 
glycosaminoglycans (GAGs). The layer connecting the dermis and the superficial 
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epidermis is the basement membrane (BM), which enables the remodeling of damaged skin 
in vitro [3]. The hypodermis consists mostly of connective tissues and fats. This layer is 
vital in the maintenance of homoeostasis and thermoregulation [4].  
Apart from the three main layers in the skin, there are also affiliated skin structures such 
as melanin and hair follicles, which are crucial to the functions of the integumentary system 
[5]. Although skin mainly consists of fibroblasts, keratinocytes, and adipose tissue, there 
are also other cell types such as melanocytes, which can produce melanin [6], and immune 
cells [7, 8]. Once the skin is impaired, these cells start to repair the wound through a 
complicated wound healing procedure.  
1.2 Wounds and wound healing process  
In healthy skin, the epidermis and dermis form a protective barrier against the external 
environment. Once damaged, the complex wound healing process that involves growth 
factors, chemokines, and cytokines will be triggered to reconstitute skin function. The 
wound healing process is mainly composed of 3 overlapping stages (Figure 1.2): 




Figure 1.2. Wound healing stages. 
1.2.1 Hemostasis and inflammation  
The first stage in wound healing is the hemostasis stage during which platelets play a vital 
role in clot formation to stop bleeding. This is mainly accomplished by the aggregation and 
release of cytokines, chemokines, and hormones [2]. Once aggregated and attached to the 
exposed collagen surface, the platelets will be activated. This activation will further enable 
platelets to degranulate and release growth factors, such as platelet-derived growth factor 
(PDGF) [9]. Fibrin will also be activated under the effect of thrombin and forms a mesh as 
“glue” to interact with platelets. This interaction will produce clots that serve to plug the 
breakage in the blood vessels to further slowing the bleeding. Besides, vasoconstriction 
[10] occurs under the effect of vasoactive mediators such as serotonin, epinephrine, 
prostaglandins, and thromboxane to prevent blood loss [11].  
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Also, the release of these components will attract circulating immunologic cells that are 
responsible for clearing out damaged and dead cells together with bacteria and other debris. 
Among these cells, macrophages and neutrophils [12] are the primary immune cells and 
are essential in the early stage of wound healing process. Macrophages are responsible for 
clearing out the debris and bacteria, secreting 5 collagenase and elastases to break down 
injured tissue. Besides, macrophages will also release PDGF to stimulates fibroblast 
proliferation, migration and division, as well as smooth muscle cell proliferation [12].  
During the inflammatory phase, T lymphocytes, which are attracted by the interleukin 1, 
also migrate into the wound and contributes to the production of collagenase [13]. 
Lymphocytes secrete wound healing related growth factors such as heparin-binding 
epidermal growth factor and basic fibroblast growth factor (bFGF) [14]. Lymphocytes are 
also crucial in antibody production and cellular immunity.  
Hemostasis and inflammation are complicated stages that complement each other with 
hemostasis responsible for limiting bleeding and tissue damage, and inflammation 
accountable for repairing the damaged tissue and preparing the wound bed for the growth 
of new tissue.  
1.2.2 Proliferation  
In the proliferation phase, angiogenesis, epithelialization, collagen deposition, formation 
of granulation tissue, and wound contraction will occur [11]. Among all these activities, 
the formation of granulation tissue is a central part. This includes accumulation of 
inflammatory cells and fibroblasts, and new blood vessel formation in a matrix composed 
of collagen, fibronectin, glycosaminoglycans, and proteoglycans [15].  
Granulation tissue is a newly formed connective tissue on the surface of a wound and is 
capable of filling in the wounds during the healing process. It is made up of tissue matrix 
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consisting of type I & III collagen, glycosaminoglycans, and fibronectin. This granulation 
tissue supports different types of cells, most of which can be associated with one of the 
following functions: formation of extracellular matrix, immunity, or vascularization [16]. 
As an essential component of the granulation tissue, fibroblasts are responsible for the 
secretion of vital skin components, including collagen, elastin, glycosaminoglycans, 
fibronectin, and proteases. During the proliferation stage, fibroblasts proliferate in response 
to different variety of growth factors produced by platelets and macrophages during the 
inflammation phase [17]. These growth factors include fibroblast growth factors (FGF), 
epidermal growth factors (EGF), and platelets derived growth factors (PDGF), which 
causes fibroblast to deposit granulation tissue in the wound [16]. Keratinocytes respond to 
EGF produced by the macrophages and keratinocyte growth factors (KGF) that are 
produced by fibroblasts.  
Epithelization is the development of an epithelium layer over a denuded skin surface. This 
process happens within hours of an initial wound and epithelial cells must have a healthy 
bed of granulation tissue to migrate across [18]. At the beginning of epithelization, basal 
epithelial cells go through conformational changes to enable them to detach from other 
epidermal cells. Then these detached epithelial cells produce intracellular actin 
microfilaments, migrate across the open wound. At the same time, they will secret 
mediators, such as transforming growth factors α and β (TGF α/β) [19]. Under the influence 
of TGF-β, fibroblasts in large wounds will differentiate into myofibroblasts. 
Myofibroblasts is a phenotype expressing α-smooth muscle actin thus able to decrease the 
wound size by gripping the wound edges and contracting [19]. Epidermal cells also secret 
collagenase that breaks down collagen as well as plasminogen activator to stimulate the 
plasmin formation. This promotes clot dissolution during epithelial cell migration. Even 
though epithelial cells migrate in random directions, the migration will be inhibited when 
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contact is formed between epithelial cells. Also, moist environments could provide a faster 
epithelialization process [20].  
Angiogenesis is another critical issue in the proliferation stage of wound healing [10]. 
Macrophages and keratinocytes are crucial to angiogenesis by producing macrophage-
derived angiogenic factors [12]. Keratinocytes are the most essential source of vascular 
endothelial growth factor (VEGF) in response to the oxygen environment resulting from 
damaged blood vessels [21]. These growth factors are essential to angiogenesis.  
Collagen synthesis and deposition are essential events in the proliferation stage. The 
abundant hydroxylysine and hydroxyproline moieties inside collagen make it possible to 
form stable crosslinks between the proline and lysine residues [22]. This crosslink happens 
in the presence of vitamin C, oxygen, and ferrous iron; thus, deficiencies of oxygen and 
vitamin C will result in weak crosslink of collagen. Therefore, it is more vulnerable to 
breakdown [23]. Elastin also appears in the wound site in a smaller amount than collagen. 
Elastin enables skin with stretch and recoil properties because of the random coils inside 
this structural protein [24].  
1.2.3 Remodeling  
The remodeling stage, which is also called the maturation stage, is characterized by the 
transmission of granulation tissue from a random network into an organized collection of 
collagen and proteoglycans with higher tensile properties [25]. During the collagen 
remodeling, collagenases, and matrix metalloproteinase coordinate to make a balance 
between the collagen synthesis and destruction [26]. Type III collagen will be replaced by 
collagen I, and fibronectin will disappear gradually. At the same time, hyaluronic acid, 
dermatan sulfate, heparin sulfate, chondroitin sulfate, and glycosaminoglycans will be 
replaced by proteoglycans, water is restored, all these events enables collagen fibers to be 
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adjacently promoting collagen crosslink, which finally decreases scar thickness and makes 
it resistant to destruction [12].  
1.3 Conventional treatments 
Depending on the extent of tissue damage, location, wound size, phase of healing, and the 
level of the exudates, the strategies for the treatment of skin lesions are different [27]. 
Among these strategies wound dressing, skin autografts and allografts are widely used 
methods.  
The use of wound dressings, such as bandages, cotton, or wool, is still deployed for wound 
healing, providing a clean cover to protect the wound from the external environment and 
stimulate wound healing [28]. Some drawbacks of this strategy include low adhesion to the 
lesion and damage induced upon removal leading to impairment of wound healing [29].  
Modern wound dressings with improved properties in keeping the environment moist, 
alleviating pain, fitting in different shapes and sizes, allowing non-traumatic removal, and 
anti-inflammatory properties have been developed to overcome the drawbacks mentioned 
above. Example compositions include alginate dressings [29], gelling cellulose fibers [30], 
foams [31], hydrocolloids [32], hydrogels [33], paraffin gauze dressings [34], silicone 
dressing [35], and silver dressings [36]. Alginates from seaweed are highly absorbent and 
turn into a gel-like substance on contact with the wound fluid. This provides a moist 
environment that can keep nerve endings moist, reduce pain, and promote the formation of 
new tissue. Some alginate dressings have haemostatic properties, thus are ideal for bleeding 
wounds [37].  
In the case of large full-thickness wounds or where the skin lesion extends to the dermis or 
hypodermis region, skin autografts, allografts, or xenografts would be used in the surgical 
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treatment. Among these strategies, skin autografts remain the current gold standard [38]. 
Full-thickness skin autografts have excellent adhesion to the wound bed, limited 
immunological rejection, and provides pain relief. But this method is limited by donor site 
shortage and may cause secondary injury. In general, autografts require the surgical 
removal of skin from another site of a person’s body [39], and autologous full-thickness 
skin transfer can only be performed for injured areas < 2% of total burned 
surface area (TBSA). Although skin allografts could prevent the wound from dehydration 
and contamination, it may lead to immune rejection.  
1.4 Skin tissue engineering 
Skin tissue engineering, which is the combination of material science and cell biology, 
offers a promising approach to produce artificial skin substitutes [40]. Skin tissue 
engineering alleviated the issue of donor shortage and prompted the wound management 
from using passive wound dressings to bioactive cell-material complex scaffolds. Ideally, 
a tissue-engineered skin substitute is a multi-layered, fully functional skin substitute that 




Figure 1.3. Skin tissue engineering. 
A typical approach to a tissue-engineered skin is to produce a two-compartment cellular 
construct with a scaffold base to simulate the native structure and organization of skin 
(Figure 1.3). The top compartment is a multi-layered epidermis-mimic that consists of 
keratinocytes (KCs). The underlying compartment, dermis-mimics, is typically composed 
of synthetic scaffolds and fibroblasts (FBs). The temporary scaffold could promote cellular 
attachment and growth. Then skin cells on it will secret extracellular matrix (ECM) to 
remodel neighboring ECM [42].  
Although the skin was the first tissue to be successfully tissue-engineered and implemented 
back into the clinical routine, there are still some disadvantages to overcome, including 
poor vascularization, pigmentation, and so on. Addressing these challenges requires 
effective and appropriate integration of key technologies in biomaterials, cells, biofactors, 
and advanced biomanufacturing.  
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1.5 Biopolymers in skin tissue engineering 
ECM components play a crucial role in every stage of the wound healing process [43, 44]. 
By providing the microenvironment for skin cells, the ECM regulates wound repair by 
influencing the development, phenotype, genetic expression, and function of all skin cells 
[45]. As such, when designing skin substitutes, bioengineered skin scaffolds should aim to 
mimic the function of natural ECM by incorporating appropriate biomaterials and 
cytokines at physiological quantities and durations [46]. Researchers have explored using 
ECM components, such as collagen, elastin, and glycosaminoglycans, as materials for 
tissue-engineered skin scaffolds. These naturally occurred biomaterials are summarized 
and reviewed here in terms of their properties and performance as skin tissue engineering 
scaffold materials.  
1.5.1 Collagen  
Collagens are the most abundant proteins by weight in the extracellular matrix and in 
connective tissue of most animals. There are several different types of collagen that are 
composed of similar or of different α chains in the triple helix of collagen fibers [22]. 
Among them, type I collagen is a significant and most abundant component of most 
extracellular material. Collagen fibers could be covalently crosslinked at their lysine sites, 
which contributes to the modulated mechanical properties of tissues with aging [47]. 
Collagen scaffolds have been used in a variety of applications due to a series of essential 
properties, such as low antigenicity, hemostatic effect, and good biocompatibilities for use 
in wound dressings and skin regeneration applications [22]. During normal wound healing 
process, collagen deposition by fibroblasts is one of the pivotal milestones in cell-material 
interaction and extracellular matrix reconstitution. Besides, collagen scaffolds were shown 
to promote cell attachment and growth. In particular, collagen contains critical residues, 
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such as lysine and arginine, and crucial integrin-binding sequences - the arginine-glycine-
aspartic acid (RGD) groups [48]. The RGD groups actively bind to integrin receptors, and 
this interaction contributes significantly to cell growth, differentiation, and overall 
regulation of cell functions. Collagen has thus been pursued in wound healing for several 
decades for its excellent biocompatibility and biodegradability. However, its fast 
biodegradation in vivo and limited mechanical strength are limitations for further use. The 
stability of a collagen-based scaffold could be improved by several approaches, such as 
adding chemical crosslinkers, or through the incorporation of synthetic polymers, or by 
engineering methods such as electrocompaction. A balance between material stiffness and 
biocompatibility should be met for a successful skin-scaffold design.  
1.5.2 Elastin  
Elastin is another principal extracellular matrix constituent providing elasticity to tissues. 
It is crucial to the elasticity and resilience of many tissues including tendon, cartilage, 
ligament, arteries, lung, and skin [49]. Especially, elastin is essential for skin structural 
integrity and is enriched in the deep dermis. Due to its densely crosslinked property, elastin 
is highly insoluble and usually exists as particles. In severe wound healing, it takes 4 – 5 
years for the burned wounds/scar tissues to re-commence elastin expression [50]. The lack 
of elastin is one of the causes of functional and spatial disorganization in scar tissue. 
Despite the apparent significance of elastin in wound healing and healthy skin function, 
few explorations of the use of elastin in dermal and skin regeneration exist. 
Although elastin is mainly known for its structural role, elastin and elastin-derived peptides 
have shown to be beneficial on wound healing and regeneration. Within skin wounds, 
various proteases act on elastin to liberate these fiber-forming proteins. This leads to 
increased collagen type I deposition, accelerated fibroblast growth and proliferation, and 
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increased tropoelastin [51]. During the skin wound healing process, dermal fibroblasts can 
differentiate into myofibroblasts to close the wound by contraction. Elastin can influence 
fibroblasts cell phenotype and function, thus affecting its differentiation [52]. Elastin is 
also required in the terminal differentiation and stratification of human keratinocytes, 
which is necessary for the reconstruction of the epidermis and the barrier function of the 
skin. A silk/elastin scaffold showed faster re-epithelialization, accelerated wound closure, 
and improved wound healing by the incorporation of elastin [53]. 
1.5.3 Proteoglycans and GAGs  
Glycosaminoglycans (GAGs) are a major group of natural compounds that exists in the 
ECM, and they play a pivotal role in providing cell-surface receptors and binding to growth 
factors and cytokines that are required for cell growth. GAGs are unbranched 
polysaccharides made up of repeating disaccharide units. The disaccharide units contain 
either of modified N-acetylgalactosamine (GalNAc) or N-acetylglucosamine (GlcNAc), 
and a uronic acid such as glucuronate (GlcA) or iduronate (IdoA).  
GAGs that are of well-known physiological importance including hyaluronic acid, heparin, 
chondroitin sulfate, heparan sulfate, dermatan sulfate, and keratan sulfate. Most of these 
GAGs are sulphated GAGs based on the type of the disaccharide units inside and are 
conjugated to a protein backbone that is expressed as proteoglycans. One molecule of a 
proteoglycan may carry more than one kind of GAG chain. GAGs are highly negatively 
charged, and a small number of GAGs can trap a large amount of water into a gel. Among 
these GAGs, hyaluronic acid is unique, as it does not contain any sulfated group and is not 
covalently connected to any protein forming a proteoglycan. HA is composed of repeating 
disaccharides of glucuronic acid and N-acetyl glucosamine. It is synthesized by enzymes 
at the plasma membrane and is abundant in many tissues. 
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GAGs are attractive bioactive polymers for tissue engineering because of their highly polar 
and water-absorbing property. In natural skin, polysaccharides are also important native 
components with functions, including maintaining moisture environment, promoting 
angiogenesis, regulating cell differentiation, and offering binding sites for drugs or growth 
factors [44]. Their negatively charged sulpho and carboxyl groups are believed to be 
critical to these functions [54]. GAGs can bind and modulate various proteins, including 
cytokines, growth factors, and extracellular matrix proteins. These interactions are 
essential for cell functions, including proliferation, adhesion, and motility [55].  As a 
consequence, GAGs are gaining more and more attention as potential components in tissue 






Table 1.1. Structure of glycosaminoglycans. 




























1.6 Roles of GAGs in wound healing 
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Abbreviations: C6S: chondroitin 6-sulfate; HDFs: human dermal fibroblast cells; HEKs: 
human epidermal keratinocyte cells; HaCaT: human  
1.6.1 HA 
HA is a significant component in skin ECM and plays an important biological role in the 
wound healing process by influencing inflammation, granulation, and re-epithelialization 
[65]. Hyaluronic acid (HA) is a non-sulfated linear polysaccharide that contains a repeating 
disaccharide of β-1,3-N-acetyl-d-glucosamine and β-1,4-d-glucuronic acid. It originates 
throughout the body, from the vitreous of the eye to the ECM of cartilage tissues.  
HA is synthesized by a family of hyaluronan synthases (HAS1, HAS2, and HAS3), of 
which HAS2 is the most critical synthase [66]. It is well known that HA is an information-
rich polymer system based purely on chain size [67]. During the wound healing process, 
HA is continuously being produced in a high molecular weight (HMWHA) form, which 
can reach over 10
6~7 
Da in molecular mass. In the inflammation stage of wound healing, 
the level of HMWHA increases quickly at the wound site, especially in the cytoplasm of 
the platelets [66]. By binding with fibronectin and its fibrin product, the HMWHA 
contributes to bleeding control by the formation and deposition of the clotted fibrin. 
Besides, HMWHA is associated with decreased inflammation by its stimulation in 
leukocyte response [68]. In the later stage of wound healing, fragmented HA (<400 kDa) 
becomes dominant, and the function of fragmented HA in wound healing involves 
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1.6.2 Heparin/ heparin sulfate 
Heparin and heparan sulfate (HS) are naturally occurring glycosaminoglycans (GAGs). 
Heparin is only produced by mast cells and functions as an anticoagulant. Heparan sulfate 
(HS) is a component of the extracellular matrix that appeared in all animal tissues. Heparin 
and HS are both linear polysaccharides composed of two basic saccharides: a uronic acid 
and an amino sugar. The uronic acid is typically either D-glucuronic acid (D-GlcA) or L-
iduronic acid (L-IdoA). The amino sugar is either N-acetyl-D-glucosamine (D-GlcNAc) or 
N-acetyl-D-galactosamine (D-GalNAc). These basic saccharides will be further modified 
by sulfation, epimerization, and deacetylation during biosynthesis.  
HS typically occurs as a proteoglycan (HSPG) with multiple HS side chains covalently 
connected to core proteins. In the skin, HSPGs are usually presented in basement 
membranes where they cooperate with other matrix materials to define basement 
membrane structure and to provide a matrix for cell function [70]. The high charge density 
of heparin makes it attractive for growth factor related-cell encapsulation because heparin 
helps to stabilize and localize these growth factors. Upon injured, heparin could relieve 
pain,  inhibit clotting and inflammation, restore blood flow, thus accelerate the wound 
healing process [70]. Low molecular weight heparins (LMWHs) are sometimes used 
instead of heparin [71]. In an abdominal rat wound-healing model, applying LMWHs to 
wounds resulted in a significant increase in collagen production at the wound site [72]. 
LMWHs induced accelerated wound healing in dorsal wound-healing models in rats in 




1.6.3 Chondroitin sulfate  
Chondroitin sulfate (CS) is a component of the extracellular matrix of all vertebrates. 
Chondroitin sulphate (CS) is a linear polysaccharide composed of (1–3)-β-N-acetyl-d-
galactosamine and (1–4)-β-glucuronic acid. Chondroitin sulfates A and C are the 
chondroitin sulfates that contain glucuronic acid in the disaccharide units instead of 
iduronic acid. CS, as well as dermatan sulfate (DS), are usually covalently connected to 
proteoglycans or as a receptor on basement membranes. CS plays a vital role in processes 
including wound repair, central nervous system, and chondrogenesis [73]. Chondroitin 
sulphate is also a vital structural component of cartilage providing resistance to 
compression. Chondroitin sulphate is a surrogate ECM and an important bio-entity for 
wound healing.  
To allow for polymerization and hydrogel formation, CS has been modified with different 
functional groups such as methacrylate [74] and thiols [75]. Prepared CS hydrogel was 
shown to stimulate wound healing by providing structural support for fibroblasts and 
epithelial regeneration. Chondroitin-6-sulfate (C6S) modified collagen gels were reported 
to be able to alter the scarring process and strengthen the mechanical characteristic of the 
matrix in the wound healing phase  [76]. 
1.6.4 Dermatan sulfate 
Dermatan sulfate (DS), formerly referred to as chondroitin sulfate B, is a 
glycosaminoglycan exists mostly in skin, but also in tendons, blood vessels, heart valves 
and lungs. DS was shown to be the most common soluble GAG that appeared in acute 
human wounds [77]. DS and CS are slightly different in structure, with DS distinguishing 
itself only by the presence of iduronic acid. 
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During the earlier phases of wound healing, DS is indispensable for the modification of 
CD44 and fibroblast migration in the granulation tissue. Besides, DS is known to bind with 
fibroblast growth factors (FGF) and mediating FGF responsiveness in the fibroblast 
through the modulation of the iduronic acid in DS [78].
 
CS and DS were also suspected to 
be essential factors in scarless fetal wound healing, as proteoglycans isolated from human 
fetal skin were shown to consist of much longer GAG chains compared with those from 
the adult human skin [79]. 
1.6.5 Keratan sulfates 
Keratan sulfate (KS), also called keratosulfate, is a glycosaminoglycan that occurs in the 
ECM and on the cell membrane surface. The basic disaccharide unit of KS is N-
acetyllactosamine and Gal(b1-4)GlcNAc(b1-3), with C-6 of GlcNAc and Gal as residues 
for sulfate esters. Keratan sulfate exists as a proteoglycan (KSPG) in which KS chains are 
attached to core proteins on cell-surface or extracellular matrix proteins, including lumican, 
aggrecan, fibromodulin, mimecan, osteoadherin, and keratocan. KS has been found in the 
cornea, skin, cartilage, and bone. KS are long, highly hydrated molecules that can perform 
as a cushion to absorb mechanical shock in joints. KS also plays a role in the nervous 
system metabolism and acting as an essential factor in the tissue damage repair [80]. 
1.6.6 Newly explored GAG-like polysaccharides 
Apart from above mentioned naturally occurred GAGs, GAG-like polysaccharides from 
other sources, such as marine biomass, have gained increasing attention as an abundant and 
sustainable source of polysaccharides. Some of these newly explored GAGs, including 
alginate, carrageenan, fucoidan, chitosan, and ulvan. These marine polysaccharides share 
similar chemical structure and functional groups as those GAGs found in ECM. They are 
also reported to have important biological properties such as biodegradability, 
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biocompatibility, anti-inflammatory, promoting wound healing, antimicrobial, as well as 
adhesive activity [81].  
Among these marine polysaccharides, there is one particular group that gains more 
attention: sulfated polysaccharides [82]. Ulvan is a sulphated polysaccharide extracted 
from the cell wall of specific green algae. It shares chemical similarities with dermatan 
sulfate and hyaluronic acid in the skin [83]. Ulvan has been shown to have a strong binding 
affinity to fibroblast cells and collagen, helping stabilize the scaffold, as well as 
accelerating fibroblast cell growth and cell spreading [60]. Carrageenan is a 
thermoreversible polymer originated from the red seaweed that presents a 
glycosaminoglycan-like structure. In a mouse full-thickness skin wound model, the 
carrageenan hydrogel was reported to reduce the inflammatory process, accelerate the 
initial recovery of the wounded area, and promote extracellular matrix deposition 
[62]. Fucoidan is a sulfated polysaccharide found in many species of brown seaweed. It 
has been shown to slow blood clotting, promote wound healing, possess anti-inflammatory 
and antioxidant activities [64]. In a low molecular weight fucoidan (LMF) treated dermal 
wounds, collagen deposition and angiogenesis were elevated in the granular tissue post-
treatment [84].  
1.6.7 Conclusion of GAGs in wound healing 
Wound healing is a complex biological process involving a series of continuous stages. 
Skin tissue engineering offered great potential for the reconstruction of skin function. 
Among the wide range of available materials for skin tissue engineering, only limited have 
been extensively used in the laboratories or clinical, such as collagen. GAGs are naturally 
occurred biopolymers and main components in skin ECM. The fact that GAGs are water-
absorbing, growth - factor trapping, biocompatible, biodegradable, and nontoxic makes 
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them suitable raw materials for the construction of the skin scaffolding system. Yet, due to 
their size-dependent and informative property, most of these GAGs are underexploited. 
Recently, there are more and more researches on GAGs in wound healing as well as other 
specific biological processes like angiogenesis, bone regeneration, and tumor growth. In 
this review, we summarized the function of GAGs in wound healing. A greater 
understanding of the function, especially the glycode provided by GAGs, will further 
enrich our understanding of wounds and finally advance the wound treatment strategies.  
1.7 Electrocompaction of collagen-based skin scaffold 
In skin tissue engineering, scaffolds are of pivotal importance in guiding cell behavior and 
controlling the transportation of nutrients and wastes. To fabricate such skin scaffolds, 
many fabrication technologies have been developed and reported. Generally, they can be 
classified into two main categories: conventional and advanced [85]. Conventional 
techniques include freeze-drying [86], casting [87], and particulate-leaching [88]. With 
these methods, scaffolds with interconnected porous structures can be created. However, 
they offer little control over pore geometry, or size, and cannot allow for the construction 
of internal channels inside the scaffolds [85].  
As an alternative to conventional methods, there are recently developed advanced 
fabrication techniques, such as 3D printing or bioprinting [89], and electrical signal guided 
fabrication methods [90] which includes electrospinning, electro-writing, and 
electrocompaction. In this research, we are particularly interested in the electrically-based 
fabrication methods. Electrical signals are especially convenient for fabrication. They can 
be controllably imposed to promote the electrophoresis, alignment, self-assembly, and 




Collagen is the most famous candidate for skin scaffold fabrication. Often the most 
challenging part for collagen fabrication is to recapitulate the aligned structure that is 
critical in matching the mechanical property of the scaffold with the neighboring tissue. A 
method named electrocompaction for the fabrication of the collagen matrix with improved 
mechanical properties was reported in 2008 [91].  
 
Figure 1.4. Application of collagen electrocompaction in tissue engineering. 
Electrocompaction has been researched in areas, including surgical suture 
[92], tendon regeneration [93], cartilage regeneration [94], skin regeneration 
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[60], corneal regeneration (2D [95] and 3D [96]), robust high porosity 
scaffolding system [97], living machine [98], and free standing nasal form 
[96]. 
During the electrocompaction process, the collagen solution was loaded between two 
oppositely charged electrodes. Upon application of an electric field, an electrochemically 
induced pH gradient will be formed. Due to the amphoteric nature of the collagen 
molecules, they will be aligned along the isoelectric point (pI) to create highly oriented 
densely packed collagen fibers that form into sheets. Variations in the electrodes size and 
shapes can help to achieve controllable and diverse structures. As such, electrocompacted 
collagen sheets or threads were applied in various areas (Figure 1.4) such as tendon 
regeneration [92], corneal regeneration [95], cartilage repair [94], conduits for nerve 
guidance [99], skin grafts [60], and orthopedic implants [100]. 
Table 1.3. Collagen electrocompaction and application. 
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1.8 Conclusion and aims of the thesis 
Wound healing is a crucial issue in massive skin lesions. Skin tissue engineering offers 
excellent potential for the fabrication of bioactive skin grafts. Among the many available 
candidates for the fabrication of skin scaffold, collagen is the most popular and extensively 
explored biomaterial. Some limitations of collagen-based scaffold include weak 
mechanical properties and the inability to mimic the aligned microstructure of collagen in 
natural skin. Electrocompaction, which is an electrochemical alignment technique to 
control collagen assemble, offered an alternative way to fabricate highly ordered, densely 
packed collagen bundles that mimic the microstructure of natural skin quite well. Apart 
from collagen, glycosaminoglycans are also crucial components with functions that include 
keeping moisture environment, promoting angiogenesis, offering binding sites for drugs or 
growth factors.  
This project aims to fabricate bio mimicking skin scaffolds and explore the application of 
such scaffolds in supporting dermis, epidermis, and full skin regeneration. Main materials 
used in this project are collagen and glycosaminoglycans including ulvan and hyaluronic 
acid. The main fabrication technique used here is electrocompaction. The proposed study 
will provide a strong base for further in vivo studies to advance development of tissue 
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2.1 Introduction  
This chapter mainly includes the chemicals, materials, instruments, cells and 
characterization methods used in this thesis. It mainly deals with protein 
electrocompaction, functionalization, characterization, human skin cell culture and 
differentiation. More details can be found in the experimental section of relevant chapters. 
2.2 List of chemicals and materials  
Chemicals and materials used in this research are listed below. They were used as received 
without further treatment unless indicated otherwise.  
Table 2.1. List of chemicals and materials used in this thesis. 
Reagent name Source Category  
Number 
Type I bovine collagen Cheng Du Kele biology 
technology 
Nil 
Ulvan Venus Shell Systems Pty Ltd Nil 
Elastin from bovine neck ligament Sigma  E1625 
Hyaluronic acid Xi’an Rongsheng 
Biotechnology 
Nil 







N-hydroxysuccinimide (NHS) Sigma 56485 
PBS tablet Sigma  P3813  
Dulbecco's Modified Eagle Medium 
(DMEM) High Glucose 
Sigma D1152 
Penicillin/Streptomycin  Gibco  15140122  
β-mercaptoethanol  Gibco 21985023  
PrestoBlueTM  Invitrogen  A13261 
Calcein AM Invitrogen  C3099  
Propidium iodide (PI)  Invitrogen  P3566  
Paraformaldehyde (PFA, 3.7% 
solution in PBS) 
Fluka  76240  
Triton X-100  Sigma  T8532  
Donkey serum  Merck S30  
Prolong Diamond antifade  Invitrogen P36965  
Rabbit Anti-collagen I, N-Terminal Sigma SAB4500362 
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Rabbit-Anti-collagen VII antibody ABCAM AB93350 
Anti-Fibronectin antibody ABCAM AB2413 
Anti-mouse/rat Ki-67 (SOlA15) Life Technologies 41-5698-82 
Rabbit polyclonal to Collagen III ABCAM AB7778 
Mouse anti-actin, a-Smooth Muscle-
Cy3 Antibody 
Sigma C6198 
Rabbit polyclonal to cytokeratin 10 ABCAM AB111447 
Rabbit polyclonal to E-cadherin ABCAM AB815148 
Rabbit polyclonal to Elastin ABCAM AB21610 
Rabbit Polyclonal to involucrin ABCAM AB53112 
Rabbit Polyclonal to Ki67 ABCAM AB15580 
Rabbit polyclonal to Loricrin ABCAM AB85679 
Donkey anti-mouse Alexa 488 Invitrogen A21202 
Donkey anti-mouse Alexa 594 Invitrogen A21203 
Donkey anti-rabbit Alexa 594 Invitrogen A21207 
Donkey anti-rabbit Alexa 488 Invitrogen  A21206  
4, 6-diamidino-2-phenylindole 
(DAPI)  
Invitrogen  D1306 
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AurumTM Total RNA 96 Kit  Bio-rad 7326800  
iScript RT Supermix, 100 rxns  Bio-rad  1708841  
SYBR® Select Master Mix  Life Technologies 4472897  
Hydrocortisone Sigma H0888 






Adenine Sigma A2786 
Cholera toxin from Vibrio cholerae Sigma C8052 
Transferrin human Sigma T8158 
Insulin solution human Sigma I9278 
Granulocyte-macrophage colony-
stimulating factor (GMCSF) 
Sigma H5666 
 




Ham's nutrient mixture F12 Sigma 51651C 
 
Keratinocyte Serum-Free Growth 




2.3 General synthesis and preparation  
2.3.1 Collagen electrocompaction 
The electrocompacted collagen sheet was fabricated following previously published 
methods with slight modifications [1]. Briefly, by applying a potential to the collagen 
solution, a pH gradient will be generated because of the electrolysis of water. Due to the 
amphoteric nature of the collagen molecules, collagen molecules will be isoelectrically 
compacted to form collagen sheets or threads along the isoelectric point (Figure 2.1.A). In 
this study, an electrocompaction station containing two electrodes and a laser-cut plastic 
rim (Figure 2.1.B) as a spacer was assembled (Figure 2.1.C). After loading the collagen 
solution, a voltage was applied and monitored using the CHI electrochemical workstation 
(Figure 2.1.D). After electrocompaction, the resultant scaffolds were incubated with PBS 
and crosslinked before using. Detailed experimental parameters could be found in Chapters 















Figure 2.1. Devices used for collagen electrocompaction. A) Mechanism of 
electrocompaction process; B) Laser-cut molds; C) Set up of collagen 
electrocompaction; D) Electrochemical workstation. 
2.3.2 Co-electrocompaction of collagen and elastin 
In this study, to explore the function of elastin in skin scaffold, insoluble elastin particles 






elastin particles were suspended into the collagen solution with a ratio of 7:1 (w/w) to 
mimic the natural ratio of collagen and elastin in skin tissues. The schematic process was 
shown in Figure 2.2. Then the mixed solution was electrocompacted and crosslinked 
following a similar procedure as described below. 
 
Figure 2.2. Illustration of co-electrocompaction of collagen and elastin. 
2.3.3 EDC/NHS crosslinking between collagen/elastin molecules 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) is a popular zero-
length crosslinker that can efficiently induce coupling between protein molecules, peptides, 
or fluorophores [2]. The term zero-length crosslinker means it can mediate crosslinking 
without EDC becoming part of the final crosslinked molecules. For higher efficiency and 
more stable couplings, EDC often comes with N-hydroxysuccinimide (NHS) or its water-
soluble analog (Sulfo-NHS). EDC, in conjunction with NHS, enables a 2-step coupling of 
proteins. Firstly, EDC activates carboxyl groups and forms an unstable amine-reactive O-
acylisourea ester. Secondly, the NHS group couples with the unstable amine-reactive O-
acylisourea ester to form a semi-stable-amine-reactive-NHS ester. This ester further allows 
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the efficient conjugation to primary amines at physiologic pH. In this research, the 
EDC/NHS crosslinking method was used in various scenarios to induce crosslinking 
between collagen or collagen/elastin sheets (Figure 2.3), mediating HA or ulvan 
incorporation onto the protein scaffolds, and to prepare the fluoresceinamine-labeled ulvan.  
 
Figure 2.3. Crosslinking between collagen/collagen or collagen/elastin 
using EDC/NHS as crosslinker. 
2.3.4 GAG coating 
In natural skin, apart from collagen, polysaccharides are also crucial native components 
with functions including hydration, promoting angiogenesis, and binding of effector 
molecules [3]. To mimic the composition of natural skin matrices and investigate the roles 
of glycosaminoglycans in wound healing process, naturally occurred polysaccharides such 
as hyaluronic acid and ulvan from seaweed source  [4] were considered in this study (Figure 
2.4). To be specific, HA and ulvan were covalently crosslinked to electrocompacted 






Figure 2.4. Molecular structure of Ulvan and HA, and crosslinking between 
HA or Ulvan with collagen. 
2.3.5 Fluorophore labeling of ulvan 
Fluorescent tagging, or labeling, is a method used to aid in the detection of some 
biomolecules such as antibodies, amino acid groups, or proteins. A fluorophore, which is 
a reactive derivative of a fluorescent molecule, is selectively bond to the target molecule, 
thus enabling detection [5]. In this research, fluoresceinamine (Figure 2.5) labeled ulvan 
was prepared by crosslinking fluoresceinamine to ulvan molecules using EDC/NHS as 
crosslinker. The resulted fluoresceinamine labeled ulvan was then being used and confocal 
inspected to localize the distribution of ulvan.  





Figure 2.5. Chemical structure of fluoresceinamine Isomer 1 (R1-NH2) and 
fluorophore labeling process of ulvan. 
2.3.6 CTAB turbidity assay 
The cetyltrimethylammonium bromide (CTAB) turbidity assay is a substitute to carbazole 
assay for HA quantification [6]. Yet, the CTAB assay is easier and faster compared with 
the carbazole assay. The CTAB assay is determined by the formation of insoluble 
compounds between cetyltrimethylammonium bromide and hyaluronic acid (Figure 2.6). 
Upon mixture of hyaluronic acid-containing solution and CTAB, insoluble compounds will 
be formed. In the reaction system, the degree of turbidity or the insoluble compounds is 
related to the amount of hyaluronic acid. The turbidity was measured using a plate reader 
at 600nm. Thus the amount of HA in the system could be calculated based on a standard 
curve of standard HA concentration vs. turbidity. In this study, the amount of HA 
immobilized to the collagen-based matrix was quantified using the CTAB turbidity assay. 
In specific, unreacted HA in the HA-collagen matrix coating system were assessed using 
the CTAB turbidity assay. Then the amount of HA immobilized to the collagen matrix was 
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calculated by the subtraction between overall HA amount and unreacted HA amount. 
Detailed calculation and standard curve were shown in Chapter 4. 
 
Figure 2.6. Mechanism of CTAM turbidity assay. 
2.3.7 DMMB assay 
The dimethylmethylene blue (DMMB, Figure 2.7) assay is widely used to quantify the 
amount of sulfated GAGs [7], such as chondroitin sulfate, heparin, or ulvan, in target 
biological samples or solutions. When bound to sulfated GAGs, the dye 
dimethylmethylene blue undergoes a change in the absorption spectrum due to the 
induction of metachromasia [8]. This enables rapid detection of sulfated GAGs in solution. 
A linear calibration curve could be obtained between 0.5-5 μg/mL of GAGs, which further 
allows the quantification of GAGs in solution. In this research, the DMMB assay was 
utilized to quantify the amount of ulvan that was incorporated into the collagen matrices. 
To do this, the target matrices were dissolved in HCL firstly. DMMB solutions were then 
added to the target solution. Absorbance at 540 nm and 595 nm of the mixture were 
recorded immediately. And a final concentration of ulvan could be calculated based on the 




Figure 2.7. Structure of the DMMB. 
2.4 Cell culture  
2.4.1 Skin cell culture 
Human dermal fibroblast cells (HDFs) and human immortalized keratinocytes (HaCaTs) 
(Figure 2.8) were utilized in this study. HDFs and HaCaTs were obtained from Sigma and 
maintained at 37°C with 5% CO2 in a humidified incubator in the growth medium of 
regular Dulbecco’s Modified Eagle’s Medium (DMEM) (D1152, Sigma) containing 10% 
fetal bovine serum (FBS) and 1% v/v penicillin/streptomycin (Life Technologies, USA). 
Cells were routinely maintained in tissue culture plates and passaged at 1:5 split after 





Figure 2.8. Skin cells used in this study. A) HDFs ,and B) HaCaTs under optical 
microscopy. 
2.4.2 Air-liquid-interface (ALI) cell culture 
The method of air-liquid interface cell culture (ALI) is designed to culture the bottom 
layers of cells in contact with media while keeping the top layers exposed to the air. To do 






initial growth. Then cells are lifted to the air-liquid interface and cultured with special 
medium to induce cell differentiation. It is primarily designed to mimic respiratory tract 
epithelial in vitro [9]. This is known to support the differentiation of 3D multilayered skin 
models [10]. In this study (Figure 2.9), HDFs were seeded into compartmentalized culture 
systems on porous filter supports as the dermal layer followed by keratinocytes cell 
seeding. After a certain initial period, cells were then lifted, exposing cells of the surficial 
layer to the surrounding air to induce differentiation. At the same time, nutritive supply to 
the cells was guaranteed by the basolateral poles in the inserts. Air-liquid interface (Ali) 
systems allow the establishment of a 3D culture environment more representative of that 
in vivo than traditional culture-plate systems. Detailed culture protocol and composition of 
differentiation medium are explained in Chapter 5. 
 
Figure 2.9. ALI co-culture of HDFs and HaCaTs. 




2.5 Physicochemical characterization 
2.5.1 Scanning electron microscope (SEM) 
The SEM uses a focused beam of high-energy electrons to interact with the surface of solid 
specimens to generate information. This information could reveal the external morphology 
(texture) and orientation of the microstructure. Before SEM imaging, biological samples 
need to be pre-processed into conductive samples. Thus, the samples were fixed and 
dehydrated, followed by gold coating of 20 nm using a sputter coater. Finally, the surface 
morphology was obtained at various magnification using a JSM-7500FA LV Scanning 
Electron Microscope (JEOL Ltd, USA). In this study, the micro-morphologies of the 
collagen gel and electrocompacted collagen were obtained and evaluated. 
2.5.2 Confocal inspection 
Confocal microscopy, or confocal laser scanning microscopy (CLSM), is an optical 
imaging technique used to obtain high-resolution images. With the advantages of 
controlled illumination of depth and area of the sample, there has been a growing number 
of applications in cell biology that rely on imaging both fixed and living tissues [11]. In 
this study, the confocal laser scanning microscope (CLSM, Leica TCS SP5, Germany) was 
firstly used to confirm the presence of elastin particles in the collagen/elastin membrane. 
Under the DAPI (4',6-diamidino-2-phenylindole) set, insoluble elastin particles have 
autofluorescence. The confocal microscope was also used for immunofluorescent staining 




Fourier-transform infrared spectroscopy (FTIR) is a technique to obtain the information of 
the absorption or emission of an infrared spectrum of a solid, liquid, or gas [12]. In infrared 
spectroscopy, an infrared (IR) radiation is passed through a sample. Due to the specific 
intrinsic property of different samples, some of the infrared radiation is passed through 
(transmitted), and some are absorbed by the sample (absorbed). The resulting spectrum 
reflects the molecular absorption and transmission, representing a molecular fingerprint of 
the sample. FTIR can be used to identify unknown materials, determine the consistency or 
quality of a sample, or used together with other methods to determine the number of 
components in a mixture. In this research, FTIR technique was used to obtain the spectrum 
of co-electrocompacted collagen/elastin sheets to demonstrate the successful incorporation 
of these two proteins. FTIR was also used to verify the amination of HA. Related spectrum 
were shown in Chapter 4. 
2.5.4 NMR 
NMR is an abbreviation for Nuclear Magnetic Resonance. NMR spectroscopy is a 
technique used to analyze the molecular structure of a material by measuring the interaction 
of nuclear spins when placed in a strong magnetic field. The principle behind NMR is that 
all nuclei are electrically charged, and many of them have spin. When a nucleus is placed 
in a strong magnetic field, it will begin to process thus has a precession frequency. If the 
sample placed in a magnetic field is irradiated with radio waves corresponding to the 
precession frequency, an NMR spectrum can be recorded (Figure 2.10). In this research, 
the NMR spectrum of the HA before and after amination (shown in Chapter 4) were 




Figure 2.10. An example of NMR spectrum. 
2.5.5 Tensile tester  
The young’s modulus, elongation to break and elasticity of the scaffold are crucial scaffold 
properties [13]. With controlled testing parameters, these data could help determine the 
maximum strength or load that a scaffold can withstand. In this research, the mechanical 
property of the scaffold was evaluated using an EZ-S mechanical tester (Figure 2.11, 
Shimadzu, Japan) using procedures as previously described [1]. The samples were cut, and 
both sides were fixed to each side of a 10 N load cell. The samples were then stressed with 
a strain rate of 2 mm/min. The Young’s modulus was calculated by a linear regression fit 
of the strain-stress curve between the end of the toe region and the midpoint of the linear 
elastic region. For each reported value, three different samples were tested, and the results 




Figure 2.11. Photo of EZ-S mechanical tester. 
2.5.6 Swelling ratio 
The swelling ratio or water/solution uptake ability of a hydrogel/scaffold is defined as the 
fractional increase in the total weight of the hydrogel/scaffold due to water absorption. It 
is an important factor when evaluating the intrinsic property of a scaffold in interacting 
with the liquid environment [14]. These scaffolds need to be able to absorb bioactive 
molecules from neighboring tissue and thus promote cell growth and function [15]. Also, 
during the wound healing process, the maintenance of moisture near the wound site is a 
critical aspect of wound management [16]. In this study, the swelling ratio of the GAGs-
incorporated scaffolds was evaluated. To do this, the initial dried weight was recorded as 
Wd. Samples were then soaked in PBS for desired time for complete hydration, and the wet 
weight (Ww) was recorded after removing excess water on sample surface using Kimwipe. 
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The swelling ratio of target matrices was calculated following the equation 2.1 as shown 
below:  
𝑆𝑤𝑒𝑙𝑙𝑖𝑛𝑔 𝑟𝑎𝑡𝑖𝑜 (%) =  (
𝑊𝑤−𝑊𝑑
𝑊𝑑
) ×  100%   (2.1) 
2.5.7 Degradability  
The stability of scaffolds over time [17] were determined in this study. To do this, a 
collagenase solution was prepared to mimic the physiological conditions [18]. In this study, 
the stability of electrocompacted collagen structure was determined by assessing the 
resistance of the matrices to collagenase treatment. With the initial dried weight of the 
target structures known, samples were immersed in the digest solution containing 100 
μg/mL (28 units) collagenase (type I, Sigma-Aldrich, Castle Hill, Australia) in PBS (pH 
7.4) and incubated for desired time points. The digest solution was replaced every 2 h. At 
desired time points, the samples were removed from the digest solution and freeze-dried. 
Then the residual mass at each time point was calculated.  
2.6 Biological characterization 
2.6.1 Cell viability assay 
Live/Dead Assay, which utilizes calcein AM for the staining of live cells and Propidium 
iodide (PI) for the staining of dead or dying cells, is a quick and easy two-color assay to 
determine cell viability (Figure 2.12). In living cells, the cell-permeant calcein AM could 
penetrate cells and react with the intracellular esterase, thus to be converted into green-
fluorescent calcein. In dying or dead cells with compromised plasma membranes, the 
membrane-impermeant propidium iodide (PI) binds to DNA with high affinity and 
generates a bright red fluorescence. In this study, samples were treated with calcein AM at 
room temperature for 10 min, followed by PI for 5 min to distinguish between live and 
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dead cells. Then, samples are ready for confocal inspection with a Leica TSC confocal 
microscope, and Image J is used to calculate the cell viability by counting the numbers of 
the live and dead cells, respectively.  
 
Figure 2.12. Mechanism of live/dead assay. 
2.6.2 Cell proliferation assay 
The proliferation behavior of cells is quantified using PrestoBlue®, which contains a cell-
permeant compound resazurin that is blue in color and virtually nonfluorescent (Figure 
2.16). When incubating with living cells, as shown in Figure 2.13, resazurin-based 
PrestoBlue® solution will turn red due to the reducing power of living cells, thus to 
quantitatively measure the proliferation of cells [19]. In this research, the cell-seeded 
samples were firstly incubated with the reagent in incubators for 30 min, the supernatant 
was then collected and transferred into a 96-well plate (Greiner bio-one, 655180), and the 
fluorescent intensity was obtained by using a microplate reader (POLARstar Omega). The 




Figure 2.13. Mechanism of cell proliferation assay using PrestoBlue. 
2.6.3 Tissue preparation and procession 
Before any staining or microscopic analysis, fresh samples or tissues need to be fixed and 
processed to prevent decay as well as to preserve tissues as close to the natural states as 
possible [20]. Also, microscopic analysis of tissues needs to be prepared to the state of thin, 
high-quality sections mounted on some specific glass slides and properly stained to show 
those complicated structures. “Tissue processing” requires fixation to maintain a state that 
is completely infiltrated with a suitable histological wax or paraffin, then prepared for 
sectioning using a microtome. In this work, tissue processing was conducted using a tissue 
processor (Figure 2.14, Leica ASP300S). During tissue processing, samples were put into 
cassettes, and a series of chemicals were applied, including formalin, 70% alcohol, 80% 
alcohol, 95% alcohol, 100% alcohol, xylene and paraffin. These chemicals were used for 
fixation, dehydration, cleaning, and embedding of the samples. After tissue processing, 




Figure 2.14. Photo of tissue processor - Leica ASP300S. 
2.6.4 Tissue embedding  
In this work, processed samples were embedded in paraffin using a Leica EG1150 
H Heated Paraffin Embedding Module (Figure 2.15.A). During this process, high-quality 
paraffin was used and melted before embedding to ensure high-quality blocks that are easy 
to cut. Tissues were then put into properly sized mold  (Figure 2.15.B) to hold the melted 
paraffin. This step should be handled gently to avoid tissue broken. Tissues embedded in 





Figure 2.15. Equipment and molds used for tissue embedding. A) Leica 
EG1150 H Heated Paraffin Embedding Module; B) Cassettes used to hold 









2.6.5 Tissue sectioning, floating and drying  
Tissue embedded paraffin blocks were then cut using a Leica RM2235 Manual Rotary 
Microtome (Figure 2.16.A). This step aims to produce a series of thin section of uniform 
thickness for optimal microscopic examination.  
In this work, sections of 7 um thickness were collected for later use. Before sectioning, 
blades and tissues in paraffin were chilled to facilitate smooth and uniform cutting. 
Sections were then floated using a Leica HI1210 water bath which allows warm water held 
within to float sections onto slides. To collect those floated sections, Polyline slides 
(Thermo Scientific, Figure 2.16.B) were used here in this work to prevent sections 
detection. Another reason for using a water bath here is sections will be slightly crinkled 
after being cut and the water bath helps to flatten these sections out. The bath was kept at 
40 oC throughout the mounting stage. Sections mounted on slides were finally dried using 






Figure 2.16. Equipment and devices used for tissue sectioning, floating, and 
drying. A) Leica RM2235 Manual Rotary Microtome for sample sectioning 
and water bath for sample floating; B) Slides used to collected floating 
sectioned samples; C) Slide drying hotplate. 
2.6.6 Cell Immunophenotyping 
Cell immunophenotyping is a general technique using immunohistochemistry reaction to 








fixed using a 3.7 % paraformaldehyde (PFA; Fluka) solution to stabilize proteins and 
preserves morphology. The samples were then blocked and permeabilized overnight to 
allow access of antibodies into cells. After that, samples were incubated with primary 
antibodies overnight, followed by incubation with Alexa Fluor-conjugated secondary 
antibody. Cell nuclei were then counterstained using DAPI at RT for 10 min. The anti-fade 
reagent was applied afterward to help preserve the fluorescent signals. Samples were 
imaged with a Leica TSC confocal microscope. 
 
Figure 2.17. Mechanism of immunohistochemistry staining. 
2.6.7 Histological staining  
The H&E staining is one of the principal tissue staining methods in histology and medical 
diagnosis [22]. It can be done quickly, cheaply, and delivers valuable information on target 
tissues. Before H&E staining, target samples need to be fixed, embedded, and sectioned to 
a specific thickness. For the sectioned sample, hematoxylin solution is applied firstly to 
stain the cell nuclei giving it a bluish or dark blue color. Then, eosin is used to stain the 
70 
 
extracellular matrix and cytoplasm pink. With other structures taking on different 
combinations of these colors, the results can reveal general distribution of cells and 
extracellular matrix and provides an overview of the sample structure.  
In this work, before H&E staining, biological samples were fixed firstly in n 3.7% PFA 
solution in PBS at room temperature for 2h. The samples were pre-processed and 
embedded in paraffin blocks. Sections of 7 μm thickness were then cut using a Reichert-
Jung 2035 microtome, collected on Polysine slides (Thermo scientific). After dewaxing 
and rehydration, the section-mounted glass slides were stained using hematoxylin solution 
(Sigma) for 10 min and then dipped in an eosin  Y  solution  (Sigma  Aldrich,  WI)  for  
60s. After washing and dehydration, the samples were sealed with coverslips using 
Permount Mounting Medium (examples of H7E stained samples shown in Figure 2.18) 
(Fisher Scientific, MA, USA). Photographs were taken on a Nikon microscope with a Leica 
DM 750 microscope (Leica Microsystems, Mannheim, Germany).  
 
Figure 2.18. Example of H&E stained section. 
2.6.8 RT-qPCR 
Reverse Transcription-quantitative Polymerase Chain Reaction RT-qPCR (RT-qPCR) is a 
laboratory technique of molecular biology based on the polymerase chain reaction [23]. It 
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is primarily used to quantify the amount of a specific RNA. RT-PCR is widely used in the 
analysis of gene expression a cell or tissue and in the diagnosis of genetic diseases. 
Typically, RT-qPCR was conducted in a two-step manner. In the first step, the mRNA of 
target samples was extracted and transcripted into complementary DNA (cDNA) using a 
reverse transcriptase. Secondly, exponential amplification of specific cDNA was achieved 
using the cDNA as templates through polymerase chain reaction (PCR). In this study, total 
RNA was firstly isolated using AurumTM Total RNA Mini Kit with the purity defined by 
NanoDropTM. The iScriptTM Reverse Transcription Supermix Kit (Bio-rad, 1708841) 
was then used to transcribe the RNA into cDNA. Finally, qPCR was performed with the 
following set up (Figure 2.19) using a SYBRTM Select Master Mix for CFX (4472942) 
using a Bio-Rad CFX real-time instrument.  
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in vitro characterization of electrochemically compacted collagen/sulfated 
xylorhamnoglycuronan matrix for wound healing application" by Kang, Lingzhi, 
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Skin is the largest organ of the human body and it acts as a physical barrier against the 
external environment. Compromised wound healing is a major issue in the treatment of 
massive skin lesions. Currently, widely used strategies to treat skin wounds include wound 
dressing, skin autografts and allografts [1]. However, these applications are limited by 
various disadvantages, such as low adhesion to lesions, donor shortage, and immune 
rejection [1]. Advances in tissue engineering have made the production of artificial skin 
possible.  
Skin tissue engineering alleviates the issue associated with donor shortage and prompts 
wound management via the use of bioactive cell-material complex scaffolds [2]. Currently, 
available tissue-engineered skin substitutes include epidermal substitutes, dermal 
substitutes, and epidermal-dermal substitutes [3]. While skin is the first type of tissue that 
has been successfully engineered for implementation into the clinical application, tissue-
engineered skin still faces a number of challenges, limiting its wider application. These 
include the inability to mimic the composition and structure of natural skin, poor 
vascularization, scar formation, missing appendages and pigmentation and high 
manufacturing costs [4]. Typically, tissue-engineered skin involves the use of 
biodegradable materials to either induce the ingrowth of surrounding cells or to act as 
temporary supports for transplanted cells to attach, proliferate and differentiate to enable 
neo-tissue genesis [5]. Thus, the role of scaffold material is crucial and this material should 
be carefully selected [6]. Among the wide range of available biocompatible materials, 
including synthetic polymers and natural polymers, preferences are given to natural polymers 
such as collagen, elastin, and polysaccharides because of their biocompatibility, 
biodegradability and presence of bonding sites with cells and bioactive molecules [7]. 
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In skin tissue, collagen is the most abundant component in the extracellular matrix, 
providing integrity, rigidity and elasticity [8]. Collagen has thus been pursued in wound 
healing for several decades [3]. In particular, type I collagen is of key importance for cell-
material interactions, as it contains crucial integrin-binding sequences including the 
arginine-glycine-aspartic acid (RGD) and glycine-phenylalanine-hydroxyproline-glycine-
glutamic acid-arginine (GFOGER) sequence [9]. However, traditionally fabricated 
collagen hydrogels mainly contain randomly distributed fiber and cannot adequately 
emulate the complexity of natural ECM and skin mechanical properties. Collagen 
electrocompaction, which is a collagen densification method that takes advantage of the 
amphoteric nature of the collagen molecules to isoelectrically compact collagen molecules 
into densely packed and highly ordered bundles [10], is a promising method to fabricate 
collagen sheet that mimics the alignment, density and mechanical properties of collagen in 
skin tissues.  
In natural skin, apart from collagen, polysaccharides are also important native components 
with functions including maintaining moisture environment, promoting angiogenesis, 
offering binding sites for drugs or growth factors [7]. Recently, marine biomass has gained 
increasing attention as an abundant and sustainable source of polysaccharides [11]. Among 
them, sulfated xylorhamnoglycuronan (SXRGlu), a sulphated polysaccharide extracted 
from the cell wall of specific green algae, is a promising candidate to explore. SXRGlu 
shares chemical similarities with natural-skin glycosaminoglycan polymers such as 
dermatan sulfate and hyaluronic acid [12], and from our previous lab trials with this 
species-specific extract, has shown a strong binding affinity to fibroblast cells and collagen, 
as well as organized structure and anti-inflammatory activity. Thus, the incorporation of 
SXRGlu is a strong candidate ingredient in electrochemically aligned collagen, as it may 
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serve as a suitable skin scaffold component substitutes for skin regeneration and wound 
healing.  
The aim of this chapter is to fabricate biomimicry dermal scaffolds using electrochemically 
aligned collagen (ECL) and SXRGlu for wound healing applications. SXRGlu was 
introduced to the ECL scaffold by chemical crosslinking, using 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide (EDC–NHS) as 
crosslinker. Physiochemical properties of the fabricated scaffolds including 
micromorphology, SXRGlu content and distribution, mechanical property, water uptake 
ability and degradability were evaluated. In addition, HDFs were cultured on the scaffolds 
to assess the cell viability, proliferation, and morphology.  
3.2 Materials and Methods  
3.2.1 Synthesis of Electrocompacted Collagen Scaffolds 
The fabrication process of traditional collagen gel (GEL), electrocompacted and crosslinked 
collagen (ECLC), as well as SXRGlu-conjugated ECLC (ECLCU) scaffold, is illustrated 
in Figure 3.1. Type-I collagen powder (Kele Biotech Co., Chengdu, China) was dissolved 
in 0.5 M acetic acid at 6 mg/mL and dialyzed against ultrapure water at 4 °C for 12 h. Then 
the dialyzed collagen was loaded into a circular rubber washer (diameter = 1.2 cm and 
thickness = 2 mm) sandwiched between two oppositely charged electrodes. Upon 
application of an electric field of 6 volts for 15 min, a pH gradient was generated between 
the two electrodes. As a result of the amphoteric property of the collagen molecules, the 
collagen molecules would be driven by the electrostatic repulsion from the electrodes and 
compacted along the isoelectric point thus forms a transparent “wet” collagen sheet (ECL). 





Figure 3.1. Schematic illustration of the preparation of electrocompacted 
collagen matrices (grey and green rods represent collagen and 
collagen/sulfated xylorhamnoglycuronan (SXRGlu) molecules, respectively). 
The colorful waves in the magnification represent electrocompacted collagen 
attached to SXRGlu (green). 
To enhance the mechanical property and stability of the collagen scaffolds, the ECL 
scaffold was crosslinked using 20 mM EDC and 20 mM NHS in 50 mM 2-(N-morpholino) 
ethanesulfonic acid (MES) buffer for 4 h at room temperature [13]. The crosslinked ECL 
scaffold (ECLC) was washed thoroughly with PBS to remove unreacted chemicals in the 
crosslinking solution. 
Traditionally fabricated collagen gels were prepared as controls by mixing the dialyzed 
collagen solution (8 parts) with 10 × PBS (1 part) and adjusting the pH to 7.0–7.5 using 
0.1 N NaOH (1 part). The mixture was then cast into molds and allowed to gel at 37 °C for 
24 h followed by crosslinking using 20 mM EDC and 20 mM NHS in 50 mM MES buffer. 
Strips or circle membranes were then cut from these gels and processed as mentioned above 
for subsequent tests. An equal amount of collagen was used for fabrication of both 




3.2.2 SXRGlu Conjugation to ECL Matrices  
To mimic the more complex scaffold structure of skin matrices and investigate the 
functions of SXRGlu in wound healing applications, an SXRGlu rich extract, obtained 
from the cell wall of a DNA barcoded green macroalgae (PhycoTrix™, Venus Shell Systems, 
Bomaderry, Australia), was crosslinked to the ECL scaffold by soaking the freeze-dried ECL 
matrices in 1% SXRGlu, 20 mM EDC and 20 mM NHS in 50 mM MES buffer for 4 h at 
room temperature. After that, the SXRGlu conjugated-ECL (ECLCU) was rinsed 
thoroughly with PBS, freeze dried and stored at 4 °C for further application. 
To quantify the amount of SXRGlu in the ECLCU scaffold, the ECLCU scaffold were 
dissolved in 1 N HCl and incubated at 37 °C for 72 h. The dimethylmethylene blue 
(DMMB) assay [14] was used to quantify the amount of SXRGlu in the solution which 
indicated the SXRGlu amount that was crosslinked to ECLCU. To visualize the 
distribution of SXRGlu through the ECLCU, fluorescent labeling and confocal inspection 
were conducted. Fluoresceinamine labeled SXRGlu (Fluo-SXRGlu) was prepared by 
mixing 25 mM EDC, 25 mM sulfo-NHS, 1.25 mM fluoresceinamine (Sigma-Aldrich, 
Castle Hill, Australia) and 5% (w/v) SXRGlu into 0.1 M MES buffer (pH 6.0) and 
incubating under gentle stirring at room temperature for 24 h. Extra dyes were removed by 
dialyzing against distilled water for 7 days. Then the Fluo-SXRGlu was crosslinked to the 
ECL using the same procedures mentioned above. 
3.2.3 SEM Inspection of the Electrocompacted Collagen Matrices 
Scanning electron microscopy (SEM, JSM-7500FA Field Emission Scanning Electron 
Microscope) inspections were conducted on GEL, ECL, ECLC, and ECLCU to investigate 
the effect of electrocompaction process on the microstructure of collagen. Samples used 
for SEM imaging were hexamethyldisilane (HMDS, Sigma-Aldrich, Castle Hill, Australia) 
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dehydrated. The fixing and dehydration process are as following [15]: freshly compacted 
collagen sample were immersed in PBS for 10 min then transferred to a fixing solution 
(2.5% glutaraldehyde in 0.2 M PBS, pH 7.0) for 0.5 h followed by washing with distilled 
water for 10 min. Samples were then immersed in graded ethanol series (50%, 75%, 90%, 
and 100%) for 10 min at each concentration for dehydration and then in HMDS solution 
for 30 min and air dried in a fume hood at room temperature. Finally, samples were 
mounted on the SEM samples stub and coated with platinum (20 nm) using an Edwards 
sputter coater and then observed using SEM.  
3.2.4 Mechanical Property 
Tensile mechanical properties of the traditional collagen GEL, ECLC, and ECLCU were 
tested using a Shimadzu EZ-L universal mechanical tester at wet state with a 10 N load 
cell at a crosshead speed of 10 mm·min−1. Before testing, samples were washed with 
deionized water, dehydrated using a series of ethanol washes, and air dried. The two ends 
of the dried bundles were glued onto transparency sheets using a UV curable glue (Dymax 
425, Dymax Corporation, Torrington, CT, USA) and rehydrated with PBS [10]. The 
Young’s modulus was calculated by a linear regression fit of the strain-stress curve 
between the end of the toe region and the midpoint of the linear elastic region. For each 
reported value, three different samples were tested, and the results were averaged. 
3.2.5 Swelling Ratio  
To evaluate the effect of electrocompaction and SXRGlu incorporation on the water uptake 
behavior of collagen matrices, samples of 0.5 × 0.5 cm2 were weighed in the dry state and 
were recorded as (Wd). Following this, samples were soaked in PBS for 24 h for complete 
hydration and then the wet weight (Ww) was recorded after removing excess water on 
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sample surface using Kimwipe. The swelling ratio of collagen matrices was calculated 
using equation 3.1  [13]: 
Swelling ratio% = (
𝑊w−𝑊d
𝑊d
) × 100                     （3.1） 
3.2.6 Degradability 
The stability of electrocompacted collagen scaffolds was determined by assessing the 
resistance of the matrices to collagenase treatment. Collagen scaffolds were freeze-dried 
and the initial weight of the matrices prior to collagenase treatment was recorded (W0). 
Following this, collagen scaffolds were immersed in the digest solution which contained 
100 μg/mL (28 units) collagenase (type I, Sigma-Aldrich, Castle Hill, Australia) in PBS 
(pH 7.4) and incubated in water bath at 37 °C for desired time points. The digest solution 
was replaced every 2 h. At t = 2 and 4 h, scaffolds were removed from the digest solution 
and freeze-dried. Then the residual mass at each time point was calculated. 
3.2.7 Human Dermal Fibroblast Cell Viability, Proliferation, and Morphology on 
Electrocompacted Collagen Matrices 
Human dermal fibroblast (HDFs, Cell Applications, Inc., San Diego, CA, USA) cells at 
passage 8 were seeded onto the fabricated collagen scaffolds to assess the influence of 
electrocompaction and incorporation of SXRGlu on cell proliferation and morphology. The 
HDFs were cultured in Dulbecco’s Modified Eagle’s medium (DMEM) with 10% (v/v) fetal 
bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin under 5% CO2 at 37 °C. 
Before cell seeding, scaffolds in 24 well plate were sterilized firstly by UV irradiation for 
1 h, immersion in 70% ethanol for 3 h and washing for five times with PBS for 12 h. To 
saturate the scaffold with cell culture medium and facilitate cell attachment onto the 
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collagen matrices, the sterilized scaffolds were incubated in 1 mL of culture medium at 37 
°C overnight before cell seeding.  
The HDFs were then seeded at the density of 1.0 × 104 cells/cm2 on the pre-processed 
scaffolds. Cell proliferation studies over 7 days were performed using the PrestoBlue™ 
(Life Technologies, Mulgrave, Australia) assay according to the manufacturer’s instruction. 
Briefly, on day 1, 3, 5, and 7, three HDFs-scaffold constructs were incubated with PrestoBlue™ 
mix for 1 h at 37 °C. Following this, for each sample, 100 μL aliquots of supernatant were 
pipetted into a 96-well plate in triplicate and measured using a microplate reader (POLAR star 
Omega, BMG Labtech, Offenburg, Germany). 
Live/dead assays were performed to inspect the HDFs cell viability on the scaffolds. 
Briefly, at each time point, HDFs-scaffold complexes were incubated with Calcein AM (5 
μg/mL, Life Technologies, Mulgrave, Australia) at 37 °C for 10 min. Then, after a media 
change, propidium iodides (PI, 5 μg/mL, Life Technologies, Mulgrave, Australia) were 
added into the HDF-scaffold complexes and incubated for 5 min followed by a further 
media change. Images were acquired using a confocal microscope (Leica TSC SP5 II, 
Buffalo Grove, IL, USA) and the 3D projection tools in the Leica application suite X (LAS 
X) software (Leica, Buffalo Grove, IL, USA) were used for depth coding.  
Alexa Fluor 488-Phalloidin cell cytoskeleton staining (ThermoFisher Scientific, Waltham, 
MA, USA) were conducted to assess the cell morphology. To do this, collagen scaffolds 
with cells at day 7 were washed in PBS and fixed in 3.7% paraformaldehyde in PBS for 10 
min at room temperature. Then, samples were washed with PBS and permeabilized with 
0.1% Triton-X 100 in PBS at room temperature for 5 min. Samples were subsequently 
stained with Alexa Flour 488-Phalloidin (1:40 in PBS) at room temperature for 1 h, rinsed 
with PBS, and then incubated with 10 μg·mL−1 4′,6-diamidino-2-phenylindole (DAPI, 
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ThermoFisher Scientific, Waltham, MA, USA) for 10 min at RT to visualize the nuclei. 
Finally, samples were washed and imaged using a confocal microscope (Leica TSC SP5 
II, Buffalo Grove, IL, USA). 
3.3 Results and Discussion 
3.3.1 Collagen electrocompaction 
After applying electrical field to the collagen solution, collagen densification was noticed. 
As shown in  figure 3.2, the thickness of the electrocompacted collagen was significantly 
decreased. This is due to the densification of collagen fibers during the electrocompaction 
process. 
 
Figure 3.2. Thickness change of collagen before and after electrocompaction. 
As an ampholytic molecule, during the electrocompaction process, the net charge of 
collagen molecules near the anode becomes positive, and those near cathodes become 
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negative [10]. Upon application of the external electric field, charged collagen molecules 
migrate until having no net charges, which is the isoelectric point. This results in the 
alignment and densification of collagen molecules along the pI plane. The method of 
electrocompaction, or isoelectric focusing, has long been used for separation of ampholytic 
proteins in areas such as biotechnology and chromatography [16]. Until recently, 
researchers started to explore it for making biomimetic materials.  
3.3.2 SEM Inspection 
SEM images of the electrocompacted collagen (Figure 3.3.A–D) showed uniformly 
oriented collagen bundle which demonstrated successful electrocompaction, whereas 
collagen gel without electrocompaction (Figure 3E) showed randomly aligned fibers with 
loosely packed pattern. Further, as can be seen in Figure 3D the D-banding pattern of 
collagen fibers are preserved after electrocompaction, which confirmed that the 
electrocompaction process was not detrimental to the native microstructure of collagen 
molecules [10]. Besides, after EDC/NHS crosslinking (Figure 3F) and SXRGlu 
incorporation (Figure 2G), the highly ordered pattern of collagen fibers in ECL was 
retained. These results are consistent with previously reported works [13] and demonstrated 
that densely packed and highly ordered collagen matrices were successfully fabricated 




Figure 3.3. Representative SEM micrographs of the electrocompacted 
collagen matrices (ECL) before crosslinking at various magnifications (A–
D), and crosslinked traditional collagen gel ((E), GEL), crosslinked ECL ((F), 
ECLC), crosslinked ECL incorporated with SXRGlu ((G), ECLCU). 
Sherman et al. [17] reported the microscopic morphology of collagen fibers in rabbit skin, 
which showed a well-organized, stacked, and wavy structure of collagen fibers. Besides, rabbit 
skin exhibited highly orientated order and densely packed pattern of collagen fibrils within 
each collagen fiber as well as the D-banding pattern in collagen fibrils. Similar orientation, 
stacking, alignment, and D-banding pattern were observed in our electrocompacted collagen 
matrices. Thus, the electrocompacted collagen matrices can preliminarily mimic the 
microstructure of collagen fibers in natural skin. Compared with other popular fabrication 
methods such as 3D printing [18], electrospinning [19], gas-forming [20], phase separation 
[21], freeze-drying [22], collagen electrocompaction poses advantages. The whole 
electrocompaction process takes only 15 min and is comparatively rapid. In addition, this 
process is simple and highly cost-effective, especially compared with those requiring 
expensive specialized instruments, such as 3D printing. Furthermore, the whole process is 
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organic solvent free while in many other methods, such as electrospinning, use of toxic 
solvents is indispensable.  
3.3.3 SXRGlu Content Quantification 
To mimic the typical scaffold structure of natural skin, SXRGlu was conjugated to the ECL 
matrices. After SXRGlu conjugation, the final content of SXRGlu confirmed by the 
calibration curve in the ECLCU was 2.1 ± 0.2%. Confocal images of electrocompacted 
collagen conjugated with Fluo-labelled SXRGlu (Figure 3.4) confirmed uniform distribution 
of SXRGlu throughout the plane and depth of collagen. This structure preliminarily 
mimicked the components of the extracellular matrix in natural skin. 
 
Figure 3.4. Confocal images of Fluo-labeled SXRGlu through the ECLCU 
scaffold, and 3D reconstruction with the pseudo-color scale indicating depth 
coding of Fluo-labelled SXRGlu along the Z-axis (0–200 μm) (scale bar 
applied to all figures). 
However, with the current EDC/NHS crosslinking method, the amount of SXRGlu that can 
be introduced into the ECLC scaffold is limited, well below the composition of 
polysaccharides in native skin, among which collagen and polysaccharides account for 
75% and 20% dry weight respectively. An alternative approach to improve SXRGlu 
loading is to develop SXRGlu derivatives that can carry both positive charge and negative 
charge, sharing the same isoelectric point with collagen [23]. In this way, SXRGlu and 
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collagen can be co-electrocompacted at any ratio. Future work will be focused on 
polysaccharides modification, such as amination, and co-electrocompaction of 
polysaccharides and collagen to better mimic the ECM structure of natural skin. 
3.3.4 Mechanical Property 
The Young’s modulus (Figure 3.5A), ultimate tensile stress (Figure 3.5B), ultimate tensile 
strain (Figure 3.5C) and strain-stress curves (Figure 3.5D) of the GEL, ECLC and ECLCU 
were obtained using tensile tests. The Young’s modulus of the ECLCU and ECLC was 
about 0.29 and 0.25 MPa respectively, which was significantly higher than that of collagen 
gel (0.13 MPa). The ECLCU had a 2-fold greater Young’s modulus and 2-fold greater 
ultimate tensile stress than the traditional collagen gel. In normal skin, the Young’s modulus 
measured from different skin sites is between 0.05 and 0.2 MPa [24]. Thus, the mechanical 
properties of the ECLC and ECLCU match natural skin very well.  
Yet, electrocompaction and crosslinking significantly decreased the extensibility of 
collagen matrices as shown by the ultimate tensile strain results. This might be due to the 
crosslinking and SXRGlu incorporation procedure reducing the mobility of collagen chains 
within the matrices, thus leading to a more rigid molecular structure which finally resulted 
in weaker elasticity [25]. This could be further improved by the incorporation of elastin 
component in the collagen scaffold. In skin tissues, fiber forming structural molecules, which 
include collagen, fibrin, fibronectin, elastin, and fibrillin [26], define the rigidity and elasticity 
of skin tissue. Typically, the extracellular matrix of dermal skin comprises 70–80% collagen 
and 3–6% elastin [27]. Elastin fibers are accountable for the recoiling mechanism after 
deformation or stress [28]. Apart from its mechanical attribute, elastin-derived peptides 
have also shown to promote cell adhesion and proliferation [16], chemotacticity [29], and 
enhance protein kinase C activation ability [30] during the wound healing process. In 
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subsequent studies, elastin will also be incorporated into the ECL system to increase the 













































































































Figure 3.5. Tensile properties of GEL, ECLC and ECLCU. (A) Tensile 
modulus; (B) Ultimate tensile stress; (C) Ultimate tensile strain; (D) Stress-
strain curve (* indicates significant difference compared with GEL at p < 
0.05). 
3.3.5 Swelling Ratio  
The swelling ratio of GEL, ECLC, and ECLCU was compared to evaluate the influence of 
the electrocompaction process and SXRGlu incorporation on the water uptake behavior of 
scaffolds. As shown in Figure 3.6, the swelling ratio of GEL was around 1040%, while the 
electrocompacted collagen matrices (ECLC, ECLCU) exhibited reduced water uptake 
ability. This could be ascribed to their electrocompacted, densified structure of collagen 
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fibers, which hindered the penetration of water molecules into the matrices. The 
incorporation of SXRGlu into the ECLCU matrices counteracted the effect of 
electrocompaction to a degree and increased the water uptake ability, which could be 
attributed to the hydrophilic nature of SXRGlu that is abundant in carboxyl, hydroxyl, and 
sulfate groups.  
Apart from fiber-forming structural molecules, components in skin ECM can be divided into 
“matricellular proteins”, and “nonfiber-forming structural molecules” [31]. Matricellular 
proteins, such as thrombospondin-1 (TSP1), osteonectin, and osteopontin, mainly act as 
signaling molecules during wound healing stage and do not participate in the structural 
construction of ECM [32]. Non-fiber forming structural molecules are mainly 
glycosaminoglycans and proteoglycans such as hyaluronan, chondroitin sulfate, dermatan 
sulfate, decorin, lumican and versican [33]. They can fill in the gaps of interstitial space 
and function in buffering, hydration and force dispersion because of their negatively 
charged and hydrophilic nature. During the wound healing process, the maintenance of 
moisture near the wound site is a critical aspect of wound management, with demonstrated 
benefits, including accelerated angiogenesis, pain relief, prevention of tissue dehydration 
and cell death. Besides, if a scaffold is capable of swelling, it will be able to absorb 
bioactive molecules from neighboring tissue and thus promotes cell growth and function 
[34]. Therefore, incorporation of SXRGlu or other kinds of glycosaminoglycans (GAGs) 
into the collagen matrices can not only increase the water uptake ability but also better 
mimic the more structured scaffold environment of natural tissue, and as is required for 



























Figure 3.6. The swelling ratio of GEL, ECLC, and ECLCU (* indicates 
significant difference at p < 0.05). 
3.3.6 Degradability 
Collagenase treatment to the collagen scaffolds was conducted to evaluate the influence of 
electrocompaction and SXRGlu inclusion on matrix stability. As shown in Figure 3.7, after 4 
h, the residual mass was only 6% for GEL and 17% for ECLC, whereas the SXRGlu 
incorporated ECLCU remained highest at 36%. These data demonstrated that both the 
electrocompaction and incorporation of SXRGlu contributed to the improved resistance to 
collagenase mediated degradation. SXRGlu belongs to a group of algal cell wall extracts that 
are known for resistance to degradation from human endogenous enzymes [12]. Thus, the 
incorporation of SXRGlu into the ECL matrices may improve the stability of the collagen 
































Figure 3.7. In vitro degradation of GEL, ECLC, and ECLCU matrices against 
collagenase (* indicates a significant difference at p < 0.05). 
3.3.7 Human Dermal Fibroblast Cell Viability, Proliferation and Morphology on 
Electrocompacted Collagen Matrices 
Cell studies were conducted to evaluate the viability, proliferation, and cell morphology of 
HDFs cells cultured on the fabricated collagen matrices. The proliferation of HDFs on 
collagen scaffolds was assessed using the PrestoBlue assay (Figure 3.8A). Quantitative 
measurement of cell viability marker PrestoBlue suggested that cell numbers on ECLCU 
and ECLC were higher than that on GEL on day 5 and day 7, which confirmed that the 
electrocompacted collagen matrices could promote the proliferation of fibroblasts. This is 
probably because the electrocompaction process increased the mechanical property of the 
matrix and this is in accordance with reports that fibroblasts responds to improved matrix 
stiffness by enhanced proliferation, collagen secretion, and smooth muscle α-actin (αSMA) 
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stress fibers expression [35]. Especially, the proliferation of fibroblast was reported to be 
highly dependent on the stiffness of the matrices, and rigid ECM tend to induce the 
differentiation of fibroblast into contractile myofibroblast [35]. Over the 7-day culture, 
there is no significant difference in cell numbers between ECLC and ECLCU, which 
showed that the incorporation of SXRGlu did not inhibit the proliferation of HDFs. Live-
dead assay in Figure 3.8B showed that nearly all cells were stained green with very few 
red cells implying that the HDFs cell viability was maintained on the electrocompacted 
collagen matrices. Compared to GEL, electrocompacted matrices showed enhanced cell 
proliferation at day 7, which is consistent with the viability test using PrestoBlue. 





































Figure 3.8. Survival and proliferation of human dermal fibroblasts (HDFs) 
on collagen matrix. (A) Proliferation (PrestoBlue™ cell viability indicator) 
of HDFs on tissue culture plate (TCP), GEL, ECLC and ECLCU matrices (* 
indicates statistical significance at p < 0.05 compared with cell numbers on 
GEL); (B) Live (stained by Calcein AM in green) and dead (stained by 
propidium iodide in red) HDFs at day 1 and day 7 (scale bar applied to all 
figures). 
The morphology of HDFs on different matrices and the arrangement of the actin 
cytoskeleton were visualized by SEM inspection and fluorescent staining of cytoskeletal 
F-actin filaments after 7 days’ cell culture (Figure 3.9). F-actin morphology illustrated a 
well-visible F-actin filament network on all these matrices suggesting HDFs attach and 
spread well on the GEL, ECLC, and ECLCU matrices. Mean HDFs cell surface area 
calculated by Image J on GEL, ECLC, and ECLCU are (960 ± 447), (1400 ± 278) and 
(2041 ± 214) μm2/cell (n = 100) respectively. HDFs on ECLCU resulted in most 
significantly increased F-actin area, indicative of most enlarged and spread out morphology 
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of the HDFs. This might because the abundant rhamnose groups in SXRGlu could trigger 
skin fibroblast recognition and attachment to the ECLCU through the mediation of a unique 
rhamnose recognizing lectin-site on fibroblasts as receptor [36]. Besides, as shown on the 
SEM images of overall morphology of cell-material complexes on Figure 8, after 
supporting the HDFs for 7 days, the GEL matrices maintained the original flat shape while 
ECLC and ECLCU have shown more pores formed and the ECLCU seemed to exhibit 
better stability than ECLC. This might be due to cell numbers on the ECLC and ECLCU 
being significantly higher than on gel at day 5 and day 7 which might result in increased 
amount secretion of collagenase thus more severe degradation of the scaffold. As cell 
numbers on ECLC and ECLCU are similar, the less severe extent of degradation on the 
ECLCU compared with ECLC might be ascribed to the incorporation of SXRGlu. This is in 
accordance with our previous results that SXRGlu could improve the stability of the collagen 
matrices against collagenase degradation.  
Together, these results demonstrated firstly that electrocompaction of collagen improved 
the mechanical property of the collagen matrices and promoted HDFs proliferation; 
secondly, the incorporation of SXRGlu facilitated HDFs spreading and enlargement on the 
electrocompacted collagen matrices; also, the incorporation of SXRGlu increased the 




Figure 3.9. Representative F-actin filament staining with Alex-488 
Phalloidin (staining F-actin in green)/DAPI (staining cell nucleus in blue) 
staining; SEM images of HDFs cultured on fabricated scaffold for 7 days; 
overall morphology of cell-material complexes after 7 days’ cell culture. 
3.4 Conclusions 
Herein we presented the fabrication and in vitro characterization of a biomimicking skin 
scaffold using collagen and SXRGlu. Electrocompacted collagen matrices were 
successfully fabricated. SEM inspection confirmed the presence of highly ordered, densely 
packed collagen fibers, mimicking the alignment and structure of collagen fibers in natural 
skin tissue more closely than the non-compacted matrix. Moreover, electrocompacted 
collagen matrices exhibited increased tensile strength and the mechanical properties of 
ECLC and ECLCU are comparable to that of natural skin. Incorporation of SXRGlu 
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significantly improved the water uptake ability and stability of the electrocompacted collagen 
matrices. Cell proliferation studies showed the electrocompacted collagen matrices 
promoted the proliferation of HDFs, and SXRGlu facilitated HDFs spreading. Together, 
these results implied the potential of this SXRGlu incorporated electrocompacted collagen 
film as a skin scaffold substitute. 
In chapter 4 and 5, two more critical components of natural skin ECM, hyaluronic acid and 
elastin, were incoporated into the electrocompacted-collagen system to fully mimic the 
components and structure of natural skin ECM. Co-culture of keratinocytes and fibroblasts 
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Skin is the largest organ of the body, protecting the internal organs from the external 
environment [1]. Advances in tissue engineering have made the production of artificial 
skin possible. Over the past several decades, remarkable efforts have been made in the 
development of artificial skin. A variety of approaches have been reported for engineering 
artificial skin [2] and 3D in vitro skin models [3]. ECM components, including collagen, 
glycan, and polysaccharides, have dominated the compositions of tissue-engineered skin 
grafts [4]. This is particularly in the case of collagen as it represents the major ECM 
component in native skin. However, the collagen-based skin scaffolds reported so far 
generally have a low mechanical strength, which results in fast degradation, severe 
contraction, and limited lifespan [5]. This could be addressed by several approaches, such 
as the inclusion of chemical crosslinkers, which might introduce additional cytotoxicity 
[6], incorporation of synthetic polymers which may reduce the compliance of the resulted 
grafts[7], or decrease the local pH and results in the inflammatory response [8].  
A simple method named electrocompaction for fabrication of collagen matrix with 
improved mechanical properties was reported in 2008 [9]. During this process, collagen 
solution was loaded between two oppositely charged electrodes. Upon application of an 
electric field, an electrochemically induced pH gradient will be formed. Due to the 
amphoteric nature of the collagen molecules, collagen molecules will be aligned along the 
isoelectric point (pI) to form densely packed and highly oriented collagen threads or sheets. 
This method is a simple, economic and versatile process as it can be carried out with 
minimum equipment at physiological conditions. Besides, varied electrodes sizes and 
shapes can help to achieve controllable and diverse structures.  As such, electrocompacted 
collagen sheets or threads were applied in variant areas such as tendon regeneration, 
corneal regeneration, cartilage repair [10], conduits for nerve guidance [11], skin grafts [12], 
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and orthopedic implants [13]. Also, different components can be incorporated for various 
applications [12]. For example, Nguyen  [14] reported the work of incorporating elastin 
within alchemically aligned collagen fibers for vascular engineering where elastin 
incorporation was found to lower the modulus and increase the yield strain. In the work by 
Kishore et al. [15], decorin was incorporated into the electrocompacted collagen threads to 
increase the mechanical property for tendon regeneration. To increase the biostability and 
mechanical property of collagen matrix, Elvis Cudjoe et al. [16] co-electrocompacted 
carboxylic acid functionalized cellulose nanocrystals (CNCs) with collagen to fabricate 
aligned micron-sized CNC fibers for repair of load bearing tissues. Younesi et al. [17] 
reported the achievement of prolonged release of growth factors by incorporating heparin 
into the aligned collagen threads.  
In our previous work [12], marine seaweed sourced polysaccharide (sulphated 
xylorhamnoglycuronan) was incorporated into the electrocompacted collagen as the first 
trail of electrocompacted matrix for wound healing application. To better mimic the 
extracellular matrix (ECM) of native skin, in this chapter, skin ECM components including 
collagen, elastin, and hyaluronic acid were fabricated together to recreate the compositional 
features of the native skin (working flow shown in Figure 4.1).  
Collagen and elastin are naturally electrocompactable molecules as both of them carry 
positively charged groups (amino groups) and negatively charged groups (carboxylic acid 
groups). They also have similar isoelectric point (pI) point that enables them to be co-
electrocompacted together [14]. Yet, HA molecules are highly negatively charged 
molecules and carries no positively charged groups. Thus naturally occurred HA are not 
electrocompactable unless modified, such as introducing positively charged amino groups 
into HA molecules. Cudjoe et. al. [16] reported a cellulose modification method to 
introduce amino groups into the cellulose molecules, making it electrocompactable. Here 
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in this chapter, to introduce HA molecules into the collagen/elastin sheets, two parallel 
procedures were tested (working flow shown in Figure 4.1). In the first procedure, HA was 
aminated following a similar method reported in [16], and then was tried to be co-
electrocompacted together with collagen and elastin. In another procedure, collagen and 
elastin were co-electrocompacted firstly, unmodified HA was then crosslinked into the 
collagen/elastin sheets by EDC/NHS crosslinking. The second procedure was chosen for 
later applications due to relatively convenience and simple operating procedures. 
Physiochemical characterization of these scaffold, including: elastin distribution, 
hyaluronic acid amount quantification, mechanical property and swelling ratio, were 
conducted. By integrating the ECM cue, the ECM-like CEH scaffold may serve as a 




Figure 4.1. Working flow of the fabrication of collagen/elastin/HA scaffolds. 
Apart from the fabrication and physiochemical characterization of the CEH scaffold, 
exploration of more versatile scaffolding system based on electrocompacted collagen  were 
conducted. Especially, tubular electrical field was applied to collagen solution surrounding 
a graphene fiber to fabricate a collagen-coated graphene scaffolding system. 
Biocompatibility characterization of such a conductive fiber was conducted. A graphene 
sheet coated with collagen was also fabricated, and possible application of such a 
conductive soft polymer was analyzed. 
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4.2 Materials and methods 
4.2.1 HA amination 
HA-COOH-NH2 was synthesized following a previously published protocol [16] with 
slight modification (Figure 4.2). Briefly, HA (0.6 mmol) was dispersed homogeneously in 
DI water (100 mL) using a sonicator, followed by the addition of EDC (6 mmol) and NHS 
(6 mmol). After fully dissolving, tert-butyl (2-aminoethyl) carbamate (6 mmol) was added 
to the solution and stirred at 50 oC for 2 h. The resultants were precipitated using excess 
ethyl acetate, filtered and washed extensively with ethyl acetate and DI water. The resulted 
animated HA were dialyzed in HCL for 1 day to remove the Boc groups, followed by 
another 3 days dialysis in DI water for further purification. The solids were freeze-dried 
and kept in the freezer for later use. 
 




4.2.2 FTIR and NMR inspection of animated HA 
Structural characterization of HA before and after animation were performed by FTIR and 
NMR. Prior to these analysis, samples were freeze-dried overnight. FTIR spectra were 
inspected in the range of 1800–700 cm−1 at a resolution of 4 cm−1 using an IRPrestige-21 
spectrometer (Shimadzu, Japan). 1 H NMR spectroscopy of HA and animated HA were 
recorded in D2O at 60 °C using a Bruker Advance III 400 MHz spectrometer (Bruker, 
Germany). The 1 HNMR spectra between 5 to −2 ppm using a relaxation delay time of 1 s 
were recorded. Chemical shift values were recorded in parts per million (ppm). 
4.2.3 Collagen electrocompaction and co-electrocompaction with elastin or aminated 
HA 
The electrocompacted and crosslinked collagen (COL) were fabricated following 
previously published methods with slight modifications [12]. The working flow is shown 
in Figure 4.3. Briefly, type-I collagen powder (Kele Biotech Co., Chengdu, China) was 
dissolved in 0.1 M acetic acid at 6 mg/mL and dialyzed against ultrapure water at 4oC for 
12 h. The dialyzed collagen was then loaded into a rectangular rubber washer (length × 
width = 1.5 × 2.5 cm and thickness = 5 mm) sandwiched between two oppositely charged 
stainless steel electrodes. By applying of the electric field of 6 volts for 15 min, a pH 
gradient between the electrodes was generated. This gradient further resulted in the self-
aggregation of collagen molecules at the isoelectric point (pI) to form a densely packed 
and highly ordered electrocompacted collagen (ECL) sheet [9].  
Co-electrocompaction of aminated HA with collagen was performed following a similar 
protocol reported in [14] with the mixture of aminated HA into the collagen solution at the 
ratio of collagen : aminated HA = 7: 2. Co-electrocompacted collagen and elastin (CE) 
sheets were fabricated with the suspension of insoluble elastin particles into the collagen 
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solution at the ratio of collagen: elastin=7:1. Then the freshly compacted ECL or CE sheets 
were incubated in PBS at 37 oC at RT for 4 h for fibril formation. To improve the stiffness 
of the fabricated matrices, the ECL and CE matrices were crosslinked using 20 mM 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC, Thermo Fisher Scientific, USA) 
and  20 mM N-hydroxysuccinimide (NHS, Thermo Fisher Scientific, USA) in PBS at RT 
for 4 h. The crosslinked ECL and CE matrices were washed thoroughly with PBS and 
deionized water and freeze-dried.  
 
Figure 4.3. Working flow of collagen electrocompaction. 
4.2.4 Confocal and FTIR inspection of elastin distribution 
In order to visually confirm the presence and uniform distribution of insoluble elastin 
particles within the CE matrices, the fibers were imaged using a confocal laser scanning 
microscope (CLSM, Leica TCS SP5, Germany), as insoluble elastin particles tend to auto 
fluorescence under the DAPI filter [14]. FTIR inspection were performed on collagen, 
elastin, and dried co-electrocompacted collagen & elastin sheet following a similar 




4.2.5 HA incorporation and quantification 
To mimic the composition of natural skin matrices and investigate functions of hyaluronic 
acid in wound healing applications, hyaluronic acid (molecular weight= 0.9 MDa) was 
crosslinked to the CE matrices to produce the collagen/elastin/HA (CEH) scaffold.  The 
procedure was shown in Figure 4.5. Briefly, the incorporation of HA was done by soaking 
the freeze-dried CE matrices in 1% HA, 20 mM EDC and 20 mM NHS in PBS for 4 h at 
room temperature. The  HA conjugated-CE (CEH) was then washed thoroughly with DI 
water, freeze-dried, and preserved at 4 oC for further application. 
 
Figure 4.4. HA incorporation into the collagen/elastin (CE) scaffolds. 
The amount of HA immobilized in a CEH matrix was quantified following a simplified 
cetyltrimethylammonium bromide (CTAB, Sigma-Aldrich, USA) turbidity assay (Figure 
4.5) [4]. To do this, unreacted HA in the HA-CE coating system were assessed firstly, then 
the amount of HA immobilized in the final CEH matrix was calculated by subtracting the 
overall HA amount and unreacted HA amount. Briefly, standard solutions were prepared 
using hyaluronic acid (molecular weight 1,000,000 Da, Sigma-Aldrich, USA) ranging from 
0.1 to 1 mg/ml. 50 uL of each hyaluronic acid standard solution was mixed with 50 uL of 
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0.2 M acetate buffer (0.2 M sodium acetate, 0.15 M sodium chloride, adjusting pH to 6 
with acetic acid) in a 96 well plate. To synchronize the reaction temperature, the plate was 
incubated at 37 oC for 5 min. Then 100 uL of CTAB in 2% sodium hydroxide was added 
carefully to the remained reaction solution. After vortexing, to prevent the disappearance 
of the insoluble compounds, the plate was read within 10 min with a plate reader at a 
wavelength of 600 nm.   
 
Figure 4.5. Mechanism of turbidity reaction between HA and 
cetyltrimethylammonium bromide (CTAB). 
4.2.6 Mechanical property 
Tensile mechanical properties of the fabricated COL, CE and CEH scaffold were tested 
following the previously published protocol [9]. Briefly, samples were immersed with 
deionized water, dehydrated using a series of ethanol washes, and air-dried. The dried 
bundles were then glued onto transparency sheets of both ends using a UV curable glue 
(Dymax 425, Dymax Corporation, Torrington, CT, USA) and rehydrated with PBS. A 
Shimadzu EZ-L universal mechanical tester was used to perform the tensile strength testing 
with a 10 N load cell at a crosshead speed of 10 mm/min-1. The fracture energy was 
calculated by an integral calculation under the strain-stress curve before failure happens.  
115 
 
4.2.7 Swelling ratio 
To evaluate the water up take behavior of different scaffolds, samples of 0.5 × 0.5 cm2  
were weighed in the dry state and were recorded as Wd. Samples were then soaked in PBS 
for 24 h for complete hydration and the wet weight was recorded as Ww after removing 
excess water using Kimwipe. The swelling ratio of scaffolds was calculated following 
equation 4.1 [18]:  
𝑆𝑤𝑒𝑙𝑙𝑖𝑛𝑔 𝑟𝑎𝑡𝑖𝑜 % =  (
𝑊𝑤−𝑊𝑑
𝑊𝑤
) × 100%                       （4.1） 
4.2.8 Exploration of versatile scaffolding system using electrocompaction 
Graphene fibers [19] or sheets were utilized in this chapter to explore the application of 
collagen electrocompaction in a versatile, robust scaffolding system [20]. To do this,  
dialyzed collagen solution at 6 mg/mL were prepared firstly. Tubular or cubic electrical 
potential (shown in figure 4.6) was applied to the collagen solution to fabricate the 
collagen-coated graphene fiber or sheets. These collagen-coated fibers were then 
crosslinked using EDC/NHS as crosslinker using the same protocol described in chapter 3. 
After sterilization using UV radiation and ethanol soaking, HDFs of passage 6 were seeded 
onto the collagen-coated graphene fiber. Biocompatibility of these fibers were then 




Figure 4.6. Collagen electrocompaction on graphene fiber or graphene sheet. 
Statistical analysis: statistical data were represented as mean ± standard deviation (SD). 
One-way analysis of variance with ANOVA) tests were used when there are three or more 






4.3.1 Hyaluronic acid amination 
Hyaluronic acid was modified following the procedures illustrated in Figure 4.2 to 
introduce amino groups to make HA electrocompactable. The reaction mechanism is that 
carboxyl groups in HA were activated by EDC, then the activated intermediate reacted 
with an amine to produce hyaluronan amide products. In this way, HA will carry both 
positively and negatively charged groups, thus make HA electrocompactable. 
As described in chapter 1, GAGs are of significant importance in the fabrication of 
functional skin scaffolding system [21]. Yet, most GAGs are highly negatively charged, 
thus un-electrocompactable. It will be of huge application if positively charged groups 
could be introduced into these GAGs to make them electrocompactable. In the works 
reported by [16], cellulose was modified to introduce amino groups according to the 
procedure described below in Figure 4.7 to make cellulose electrocompactable. Due to the 
similarity between the chemical structure of cellulose and HA or ulvan, HA was modified 
in this work with the aim to make HA electrocompactable and to co-electrocompact 




Figure 4.7. Modification of cellulose to introduce amino groups. 
4.3.2 FTIR and NMR of aminated HA 
Then FTIR characterization was conducted before and after HA animation to examine the 
chemical bond changes. As shown in Figure 4.8 A, after modification, a significant 
difference in the transmittance peaks was noticed near 1625 cm-1, which is corresponding 
to the N-H asymmetric bend in the amino groups [22]. This was assigned to the 
incorporation of amino groups. This was further confirmed by 1H NMR of HA before and 
after modification. Among many peaks on 1 H NMR spectra of HA, the broad signal 
between 3.0 and 3.8 ppm corresponds to the signals of the protons in the sugar rings [23]. 
The peak at δ = 1.9 ppm is assigned to the methyl (-CH3) protons of the N-acetyl group of 
HA. The appearance of a peak at δ = 2.8 ppm of the modified HA 1H NMR (shown in 
Figure 4.8 B) corresponds to the newly introduced methylene group in the modified HA. 
This spectrum change was in accordance with that reported elsewhere [24]. 
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Figure 4.8. FTIR and NMR characterization of HA amination. A)FTIR and 
B)1H NMR spectrum of HA before and after modification confirmed 
successful amination of HA. 
4.3.3 Collagen electrocompaction and co-electrocompaction with aminated HA or 
elastin 
Co-electrocompaction of the aminated HA and collagen was tried afterward yet with 
unsatisfactory results (data not shown). To co-electrocompact HA and collagen, the pI of 
these two materials should be adjusted to a similar range. As this electrocompaction 
process is dependent on the net charge of molecules to be processed, where these net 
charges are further on account of the pH-sensitive groups (carboxylic acid and amines) 
contained in the molecules. Collagen molecules have + 0.8 coulombs of charge at pH 11 
and − 0.8 coulombs of charge at pH 3 [16]. To achieve a similar pI point between collagen 
and HA, more precise control of the ratio between amino and carboxylic acid groups in the 
HA molecules need to be obtained. In this research, to introduce HA molecules into the 
protein system in a cost-effective and convenient manner, the EDC/NHS coupling method 
was chosen to incoporated HA into protein sheets. 
Electrocompaction of collagen and elastin was conducted according to the schematic 
procedures in Figure 4.3. To test the feasibility of incorporating elastin particles within 
aligned collagen fibers and to better mimic the components and morphology of natural skin 
tissue, elastin was mixed with the collagen solution at different weight ratios: collagen 
only, collagen: elastin at 3:1 and 1:1, and co-electrocompacted.  As shown in figure 4.9, 





Figure 4.9. Co-electrocompaction of collagen and elastin at different ratios. 
4.3.4 Confocal  and FTIR inspection 
To investigate the distribution of elastin particles inside the collagen membranes, the 
resulted CE membrane was inspected by confocal. The fluorescent imaging of CE (Figure 
4.10 A) confirmed  the successful incorporation and uniform distribution of elastin into the 
CE membranes as insoluble elastin particles have auto-fluorescent blue color under the 
DAPI set. This was further confirmed by conformation changes of the amide II peaks in 










Figure 4.10. Characterization of elastin distribution in co-electrocompacted 
collagen and elastin sheets. A) Confocal, and B) FTIR inspection confirmed 
successful co-electrocompaction of collagen and elastin. 
4.3.5 HA incorporation and quantification 
To mimic the natural ECM components, HA (MW = 0.9 MDa) was coated onto the co-
electrocompacted CE scaffold using EDC/NHS as crosslinker. The quantification of HA 
content in the CE membrane was performed following the standard CTAB turbidity assay 
[25]: Insoluble complexes will be formed upon the mixture of hyaluronic acid with CTAB. 
The amount of insoluble complexes is in proportional to the amount of hyaluronic acid in 
the testing system (Figure 4.11). The amount of insoluble complexes, which could be 
reflected by the turbidity, could be measured using a plate reader at the wavelength of 600 
nm. By adjusting the amount of HA added, the maximum amount of HA-coated on the CE 
scaffold was (26.4 ± 3.3) % which is suitable to mimic the ratio of polysaccharides in 
natural ECM [26] . 
 
Figure 4.11. Standard curve of HA concentration in terms of turbidity. 
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4.3.6 Mechanical property  
The young’s modulus (Figure 4.12.A) and ultimate tensile strain (Figure 4.12.B) of the 
COL, CE, and CEH were obtained from tensile tests. The young’s modulus of the CE was 
about 0.17 MPa, which was significantly lower than that of COL (0.25 MPa). This could 
be ascribed to the incorporation of elastin particles that disturbed the alignment of collagen 
bundles. This is in accordance with the pervious report [27] that insoluble elastin particles 
reduce collagen scaffold stiffness in a concentration-dependent manner. After HA 
incorporation, the CEH (about 0.35 MPa) had a 2-fold greater young’s modulus than the 
CE scaffold. This might due to the enhanced crosslinking between HA and collagen. 
The ultimate tensile strain reflected the maximum elongation before a scaffold fail. As 
shown in Figure 4.12.B, the ultimate tensile strain of the CE scaffold was about 30% and 
was similar to that of the COL scaffold. The CEH resulted in a significantly higher ultimate 
tensile strain (about 44%) than the CE scaffold. In normal skin, the reported young’s 
modulus of various skin sites and ages are roughly between 0.05 and 0.2 MPa [28]. The 
range of ultimate tensile strain of natural skin is 40–70% [29]. Thus, the mechanical 
properties of the fabricated electrocompacted collagen scaffold lies in a suitable range to 




Figure 4.12. Mechanical properties of COL, CE, and CEH scaffolds. A) 
Ultimate tensile strain, and B) Fracture energy of the fabricated COL, CE, 
and CEH scaffold (* indicates p < 0.05). 
4.3.7 Swelling ratio 
The water uptake behavior of COL, CE and CEH scaffold was evaluated. As shown in 
Figure 4.13, the equilibrium water content of CEH was around 920%, while the 





content. This could be ascribed to the hydrophilic and highly water-absorbing nature of 
HA that is abundant in carboxyl and hydroxyl groups. The incorporation of elastin into the 
electrocompacted collagen system did not cause significant change in the equilibrium 
water content between COL and CE. 
 
Figure 4.13. The swelling ratio of the COL, CE and CEH scaffold. 
4.3.8 Exploration and examples of  versatile application of collagen coated graphene 
Collagen coated graphene sheet and fiber were successfully fabricated and shown below 
in Figure 4.14. During the electrocompaction process, the electrical field pushed the 
collagen molecules to the pI point, which located near the graphene sheet or fiber. Collagen 





Figure 4.14. Collagen electrocompaction on graphene fiber. 
To further demonstrate the biocompatibility of the collagen-coated graphene fiber, HDFs 
were seeded onto the fiber and cultured for 5 days. The live/dead assay result was shown 
in Figure 4.15.A. The result showed that most of the cells were alive. This implied that this 






Figure 4.15. Biocompatibility of collagen-coated graphene fiber and its 
possible application as nerve guidance channel. A) Live/Dead assay of HDFs 
cultured on the collagen-coated graphene fiber, and B) Schematic illustration 
of nerve guidance channel for nerve regeneration. 
One possible application of this collagen coated graphene fiber is nerve guidance channel 
for nerve regeneration. Previous work showed that electroconductive scaffolds, such as 
polypyrrole (PPY), can improve peripheral nerve injuries significantly [30]. Polypyrrole 
(PPY) is an electroconductive polymer with good cell compatibility that has shown great 
potential as a nerve scaffold [31]. As the collagen-coated graphene fiber showed similar 
functions, including conductivity and biocompatibility, this collagen-coated graphene 






Figure 4.16. Collagen coated graphene sheets and its possible application as 
soft conductive polymer. A) Collagen coated graphene sheet, and B) 
Schematic illustration of a biofuel transdermal iontophoresis patch based on 
collagen-coated graphene sheet; C) Example of one possible application of  
the collagen-coated graphene: An organic transdermal iontophoresis patch 
for sustained drug release [32]. 
Collagen coated graphene sheet was also fabricated, as shown in Figure 4.16.A. This 
collagen-coated graphene sheet could be potentially used as a soft conductive polymer 
to apply electrical signal to the wound site and stimulate wound healing. Min Zhao 





generated near the wound site. Y Ogawa et. al. [32] reported the fabrication and 
application of an organic transdermal built-in biofuel cell with the function of 
sustained drug release property. For such an application, highly conductive, 
biocompatible and enzyme coated  polymers were needed. This could be achieved by 
the co-electrocompaction of related enzymes with collagen onto the graphene 
membrane. 
4.4 Discussion 
The native skin ECM is an active and complex place that can influence cell proliferation, 
migration and differentiation. Due to their capability to influence the wound healing 
process, ECM components are valuable building blocks for researching bioactive wound 
dressings and skin regeneration [34]. Natural skin ECM is mainly made up of collagen, 
proteoglycans and polysaccharides, and elastin and glycoproteins with the a ratio of 
roughly 7:2:1 [26]. With collagen provides the structural integrity of the skin tissue, elastin 
helps to retain mechanical compliance and elasticity of the skin, which makes elastin and 
ideal protein for dermal skin scaffold design [35]. However, the structural-functional 
relationship of native elastin is difficult to explore due to the protein's large size and 
insolubility [27]. Therefore, many researches have focused on elastin derived components, 
such as hydrolyzed elastin [36], tropoelastin, which is its soluble precursor [37], or elastin-
based peptides [38]. While this brings more clues of the molecular basis for elastin's 
mechanical and biological function, the application of the native insoluble elastin particles 
provides more advantages for biomimicry tissue engineering. Thus in the current study, 
insoluble elastin particles (<37 μm) were incorporated into the collagen scaffold at a weight 
ratio of collagen: elastin=7:1 to closely mimic the composition of natural skin tissue [26]. 
During the electrocompaction process, the elastin particles got trapped in between the 
aligned collagen bundle to form the elastin-incorporated collagen-elastin (CE) membranes. 
131 
 
After the co-electrocompaction of collagen and elastin, HA was incorporated into the 
scaffold by crosslinking to fabricate the resulted collagen/elastin/HA (CEH) scaffold. HA 
is a major GAGs in skin ECM and was reported to have significant biological roles in 
wound healing process by influencing inflammation, granulation, and re-epithelialization 
[34]. Besides, by incorporating HA into the collagen/elastin scaffold, the swelling ratio of 
the final scaffold were significantly improved. This is crucial for a successful skin 
scaffolding system. During the wound healing process, the maintenance of moisture near 
the wound site is an important aspect of wound management [39]. Besides, a better swelling 
property can also help the scaffold absorb bioactive molecules from neighboring tissue and 
thus promote cell function and tissue generation [30]. Therefore, the incorporation of HA 
or other kinds of glycosaminoglycans (GAGs) into the collagen scaffolds can not only 
increase the water uptake ability but also better mimic the micro-environment of natural 
skin tissue. 
Often the motivation and most challenging part for collagen fabrication is to recapitulate 
the aligned and hierarchically organized structure, as well as matching the mechanical 
property of the fabricated collagen graft with the neighboring tissue. In skin, collagen fibers 
exist in a densely packed and highly ordered pattern [22]. The method of 
electrocompaction, which takes advantage of the amphipathic feature of collagen 
molecules to fabricate densely packed and highly ordered collagen sheets, perfectly meets 




Figure 4.17. Endogenous electrical field in health skin. 
Besides, using electrical signal to fabricate biomimicry skin graft is more intrinsic. Across 
the skin tissue, asymmetric ionic flows created transepithelial electric potential where the 
ECM exists naturally (Figure 4.17) [40]. Thus, the method of applying electric field onto 
ECM protein molecules (collagen and elastin) mimicked the natural way how collagen 
fibers are deposited and aligned. Also, electrical signals are especially convenient for 
fabrication as they can be controllably imposed to promote the electrophoresis, alignment, 
self-assembly and functionalization of macromolecules to generate hierarchically 
organized material systems [41]. 
Before exclusively characterize the biological function of the fabricated ECM components-
based skin scaffold, more possible applications of the collagen electrocompaction method 
were explored. Even though various applications of the collagen electrocompaction were 




Figure 4.18. Electrical potential on skin after wound. 
Electricity in animals was detected in the eighteenth century [33]. Naturally occurring 
electric fields are known to be crucial cues directing tissue growth and healing [40]. In skin, 
endogenous electrical will be generated instantaneously upon skin injury. Such an 
electrical field were reported to be fundamental signals directing cell migration during the 
wound healing process (Figure 4.18) [33]. Even though, exploration of how electrical field 
affects wound healing in  is not the focus of this thesis, it’s worth noting that  electrical 
cues are crucial signals in tissue growth and regeneration. It is highly meaningful and 
desirable to develop practical and reliable techniques for tissue engineering techniques 
exploiting electrical signals. The combination of collagen electrocompaction with 
graphene, as explained in this chapter, could be one cue for such technique. 
4.5 Conclusion 
Development of biomimetic structures with integrated extracellular matrix (ECM) 
components represents a promising approach for biomaterial fabrication. In this chapter, 
we reported an artificial ECM comprising the structural protein collagen I (COL) and 
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elastin (ELN), and glycosaminoglycans (GAGs) hyaluronan (HA). Specifically, collagen 
and elastin were electrochemically aligned to mimic the morphological and mechanical 
characteristics of dermal matrix. For HA incorporation, HA amination and co-
electrocompaction with collagen was tried yet with unsatisfactory results. Alternatively , 
HA was finally incorporated into the electrocompacted collagen-elastin (CE) matrices via 
adsorption and chemical immobilization, to give a final composition of 
collagen/elastin/HA of 7:2:1. This produced a final collagen/elastin/hyaluronic acid 
scaffold (CEH) that recapitulated the structural and compositional features of the native 
skin ECM. Physiochemical characterizations demonstrated its superior properties in 
components distribution, mechanical properties, and water uptake behavior. In chapter 5, 
in vitro biological characterization of this ECM-like scaffold, including biocompatibility, 
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Skin is the largest organ of the body protecting the internal organs from the external 
environment [1]. Wounds, originating from physical or chemical trauma, can significantly 
compromise the skin barrier and impair its physiological functions. In the instances of 
extensive or deep wounds, it is essential to replace the impaired skin using (bioengineered) 
skin grafts to prevent water loss and opportunistic pathogens, and to facilitate the wound 
healing process to restore the barrier structure and functions [2]. Beyond wound healing 
applications, at the early stage of drug discovery or cosmetic formulation development, 
tissue-engineered skin can serve as an in vitro platform to assess the properties of a 
pharmaceutical or cosmetic agent, such as permeability and the adverse inflammatory 
responses. Tissue-engineered skin models can also be useful tools for elucidating the 
pathophysiological mechanisms of skin diseases in vitro [3].  Further, the ban on animal 
testing for cosmetic industries since 2013 has increased the need for development of in 
vitro skin models that best mimic the native skin [4]. 
In chapter 4, an ECM-like skin scaffold, including collagen, elastin, and hyaluronic acid, 
were fabricated and evaluated in terms of its compositional information, mechanical 
property, and water uptake ability. In this chapter, biological characterizations of this 
scaffold were conducted. The hypotheses of the function of this ECM-like scaffold include, 
(1) the CEH scaffold could support dermal skin cell growth and ECM production; (2) the 
CEH scaffold could support epidermal skin cell growth and stratification; (3) the CEH 
scaffold could support the organotypic co-culture of human skin fibroblast cells and 
keratinocyte cells for the formation of the two-layered stratified skin tissue structure. To 
test these hypotheses (working flow is shown in Figure 5.1), scaffolds with different 
combinations of ECM components including collagen, elastin, and hyaluronic acid, were 
synthesized. Human dermal fibroblast cell line: HDFs and human epidermal keratinocyte 
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cell line: HaCaTs were used in this work to evaluate the influence of the fabricated scaffold 
on skin cells. Finally, the organotypic co-culture of HDFs and HaCaTs were conducted to 
evaluate the ability of this CEH scaffold in supporting two-layered skin tissue 
reconstruction. 
 




5.2 Materials and methods 
5.2.1 HDFs cell viability and proliferation on the COL, CE, and CEH scaffolds 
To evaluate the ability of these ECM-like scaffolds in supporting HDFs growth and dermal 
layer formation, HDFs cell behavior on the COL, CE, and CEH scaffolds, including cell 
proliferation, cell viability, protein expression, and new ECM deposition, were assessed. 
To be specific, HDFs at passage six were seeded on the sterilized scaffolds at a cell density 
of 5 × 104 cells⁄cm2. The cell-seeded scaffolds were then cultured in the growth medium 
containing regular Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma) containing 
10% fetal bovine serum (FBS) and 1% v/v penicillin/streptomycin (Life Technologies, 
USA). Cells were then maintained in a 24 well plate in 5% CO2 at 37°C. 
Cell proliferation over 14 days was assessed using the PrestoBlue™ (Life Technologies, 
Australia) assay. Briefly, on day 1, 4, 7, and 14, three HDFs seeded scaffolds were 
incubated with PrestoBlue mix for 1 h at 37 oC. After this, for each sample, 100 µL aliquots 
of supernatant were transferred into each well of a 96-well plate in triplicate and read using 
a microplate reader (POLAR star Omega, Germany). 
To examine the cell viability on scaffolds, the live/dead assay of cells cultured on scaffolds 
were conducted. Briefly, after culturing for 7 days, the cell culture medium was replaced 
by calcein AM (5 μg/mL, Life Technologies, Australia) and incubated at 37 oC in dark for 
10 min. After washing in PBS for 3 times, propidium iodides (PI, 5 μg/mL, Life 
Technologies, Australia) were added into the cell-scaffold complexes and incubated for 5 
minutes in dark at 37 ◦C. Photographs were taken using a confocal microscope (Leica TSC 





To analyze the influence of matrix composition on HDFs gene expression, the mRNA 
levels of collagen type I (COL1), collagen type III (COL3), elastin (ELN), fibronectin (FN), 
CD44, hyaluronan synthase 2 (HAS2), α-smooth muscle actin (α-SMA), and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH, housekeeping gene) were 
evaluated. To do this, HDFs were cultured on the COL, CE, or CEH scaffolds for 14 days. 
Total mRNA was then isolated using the Aurum Total RNA Mini kit (Bio-Rad, USA). The 
concentrations of mRNA were determined using a Nanodrop spectrometer (Thermo Fisher 
Scientific, USA). Complementary DNA (cDNA) was synthesized, and specific primers for 
target gene (Table 1) were designed based on the gene sequence database of NCBI. 
Forward and backward primers were purchased from Sigma. RT-qPCR was run with 
SYBR® Green Master Mix (Bio-Rad, USA) using a 7500 Real-Time PCR system (Thermo 
Fisher Scientific, USA). The gene expression levels were normalized with GAPDH, and 
the data were finally analyzed according to the 2–ΔΔCT method. 
5.2.3 Immunohistochemistry staining of HDFs differentiation and new ECM 
secretion  
Immunohistochemistry staining was performed to evaluate the influence of three types of 
scaffolds on HDFs differentiation with α-SMA as maker. New ECM deposition by the 
HDFs cultured on the CEH scaffold were also evaluated. To perform this, samples were 
fixed with 3.7% PFA in PBS at RT for 30 min, rinsed in PBS, blocked and permeabilized 
with 5% (v/v) donkey serum in PBS containing 0.3% (v/v) Triton X-100 (Sigma) at 37 oC 
overnight. Samples were then incubated with fluorescence conjugated antibodies mouse 
anti-α-smooth muscle-actin-Cy3 (α-SMA, 1:100, Sigma), or unconjugated primary 
antibodies collagen I (COL1, Abcam), collagen III (COLIII, Abcam), fibronectin (FN, 
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Abcam), and elastin (ELN, Abcam) from rabbit at 1:100 dilution at 4 oC overnight. On the 
second day, samples were rinsed with 0.1% Triton X-100 in PBS three times. Samples with 
unconjugated primary antibody were then treated with Alexa Fluor 488 or 596-conjugated 
secondary antibody (5:1000; Invitrogen) and incubated for 2 h in dark at 37 oC. After 3 
times wash with PBS,  cell nuclei were counterstained with 4, 6-diamidino-2-phenylindole 
(DAPI, 5 μg mL-1) for 10 min in dark at room temperature. Samples were mounted onto 
glass coverslips with Aquamount (ThermoScientific). Visualization of samples was 
performed using a confocal laser scanning microscope (Leica TSC SP5 II) applying Leica 
Application Suite AF (LAS AF) software (Leica). 
5.2.4 HaCaT cell culture and differentiation 
The CEH scaffold was employed for the culture of keratinocytes. HaCaT cells (source) 
were routinely cultured in 5% CO2 at 37°C in DMEM supplemented with 10% FBS. The 
scaffolds were placed into 12 well transwell with inserts of polycarbonate membrane (12 
mm diameter and 3 μm pore size, Corning Inc., USA). Then HaCaT cells (passage 9) were 
seeded at a density of 0.2 × 106 cells cm-2. Each cell-seeded scaffold was cultured in 1.5 
mL growth medium under submerged condition in 5% CO2 at 37°C for 24 h for the 
formation of confluent monolayers. The cell culture medium was replaced with 600 µL 
differentiation medium to expose HaCaT cells to the air-liquid interface for 7-14 days to 
induce differentiation and stratification. The differentiation medium was prepared as 
described in [21] with slight modification. Briefly, DMEM/F12 (3:1, v/v) were 
supplemented with 10% FBS, 1% penicillin/ streptomycin, 1.8 mmol L−1 Ca2+, 5 μg mL−1 
insulin, 0.4 μg mL−1 hydrocortisone, 0.02 nM triiodothyronine, 0.18 mmol L−1 adenine, 5 
μg mL−1 transferrin, and 2 ng mL−1 transforming growth factor α (TGF-α). The 
differentiation medium was changed on a daily basis.  After culturing for 7 days, HaCaT 
cell viability were evaluated using the live/dead assay as described above. 
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5.2.5 Histology analysis 
To observe the stratified multilayer of the resultant epidermis,  samples  (cultured  at air-
liquid-interface (ALI) for 1  and  2  weeks)  were fixed in 3.7% PFA solution in PBS at 
room temperature for 2 h and rinsed in PBS. The samples were pre-processed and 
embedded in paraffin block for routine hematoxylin and eosin (H&E) histology and 
immunofluorescence staining. Sections of 7 μm thickness were cut using a Reichert-Jung 
2035 microtome, collected on Superfrost microscope slides (Fisher Scientific, USA). After 
dewaxing and rehydration, the section-mounted glass slides were immersed into a 
hematoxylin solution (Sigma-Aldrich, USA) for 10 min, washed with warm running water 
for 15 min, and then dipped in an eosin Y solution  (Sigma-Aldrich, USA)  for  60s. After 
washing with tap water for 1 min, the sectioned samples were dehydrated by immersing 
sequentially in 95% ethanol, 100% ethanol, and xylene, twice and 2 min each. The labeled 
samples were sealed with coverslips using Permount Mounting Medium (Fisher Scientific, 
USA). Photographs were taken on a Nikon microscope with a Leica DM 750 microscope 
(Leica Microsystems, Mannheim, Germany). Tissue thickness of the sectioned epidermis 
was measured on histological sections using the ImageJ software (NIH). 
Immunohistochemistry staining was conducted on the samples after ALI culture for 14 
days, to assess the differentiation and stratification of HaCaT cells cultured on the CEH 
scaffold. Samples were harvested and sectioned using the same procedure as mentioned in 
chapter 2.3.2. The sectioned samples were stained against markers including Ki-67 (a 
proliferation marker), E-cadherin (a cell-cell adhesion marker), involucrin and loricrin 
(terminal differentiation marker of keratinocytes). Confocal images were collected using 




5.2.6 Organotypic co-culture of HDFs and HaCaTs on the CEH scaffold 
To reconstruct double-layered epidermal-dermal like structure, HDF cells (passage 6) were 
seeded on top of the CEH scaffold at a density of 2×105 cm2 and cultured in the growth 
medium for 48 h. Then HaCaT (passage nine) cells were seeded on top of the construct at 
a density of 1×106/cm2 and co-cultured under submerged condition in the growth medium 
for 24 h, following by the ALI culture for 14 days according to the procedure described in 
2.3.1. To view the resulted doubled-layered epidermal/dermal structure, the co-cultured 
samples following the ALI culture for 14 days were harvested and sectioned. H&E staining 
was then performed to visualize the resulted stratified epidermal-dermal structure. To 
further demonstrate the formation of two-layered skin structure, immunohistochemistry 
staining of epidermis markers (E-cadherin, Involucrin, and Loricrin), dermis marker 
(collagen I), and cell nuclei were also applied. 
Statistical Analysis: statistical data were represented as mean ± standard deviation (SD). 
One-way analysis of variance with ANOVA) tests were used when there are three or more 






5.3.1 HDFs cell viability and proliferation on the COL, CE, and CEH scaffold  
To examine the ability of the COL, CE, and CEH scaffold in supporting fibroblasts growth, 
HDFs cell viability and proliferation on these scaffolds were evaluated. Figure 5.2.A 
showed the live/dead assay of cultured HDFs on three types of scaffolds for 14 days. On 
day 1, HDFs cell attachment were noticed on all three types of scaffold. On day 14, 
confluent HDF cell layers on all scaffolds were observed. This suggested the HDFs could 













Figure 5.2. Survival and proliferation of human dermal fibroblasts (HDFs) 
on the fabricated scaffold. A) Live (stained by Calcein AM in green) and dead 
(stained by propidium iodide in red) HDFs at day 1 and day 14; B) 
Proliferation of HDFs on the COL, CE, and CEH scaffold. 
The proliferation behavior shown in Figure 5.2.B demonstrated again that  all these 
scaffolds supported cell growth and proliferation. Especially, cell number on CE at day 10 
and day 14 were significantly less than that on COL. This is probably ascribed to the 
reduced mechanical properties of the CE scaffold as a result of elastin inclusion that 
comprises the alignment of collagen fiber [16]. The inclusion of HA seemed to be able to 
counteract this reduction in the CE scaffold as cell numbers on the CEH scaffold were 
significantly higher than that on the CE scaffold and similar to that on COL. This might be 
because, firstly, GAGs, including HA, were reported to be able to sequester and concentrate 
growth factors or nutrients from the neighboring environment, therefore, induce a superior 
condition for cell function [27]. Secondly, the incorporation and crosslinking of HA into 




stimulate HDFs proliferation [28], and this is in accordance with the tensile mechanical 
results in Figure 1.D.  
However, it was interesting to note that, while the CEH scaffold was stiffer than the COL, 
the increased stiffness did not result in higher cell proliferation on the CEH scaffold. This 
might be because not all biologically derived polymers are suitable substrates for cell 
growth. Even though collagen itself is highly cell adhesive and cell growth supportive, 
elastin and HA are not as friendly in terms of supporting cell attachment. Elastin was 
reported to discourage cell attachment and growth unless otherwise modified [29]. To fully 
explain the influence of elastin and HA incorporation on initial cell attachment on the 
scaffold, more detailed work was planned for the future work. 
5.3.2 RT-qPCR  
To study the influences of the COL, CE and CEH scaffold on HDFs gene expression, 
mRNA levels of HDFs cultured on different scaffolds for 14 days were examined.  Selected 
genes are those related to fibroblast ECM deposition, including collagen type I (COL1), 
collagen type III (COL3), vimentin (VIM), fibronectin (FN), elastin (ELN), and cell 
function, including CD44 (cell attachment and migration), hyaluronan synthase 2 (HAS2, 
hyaluronic acid synthesis), and α -smooth muscle actin (α -SMA, maker of myofibroblast 







Table 5.1. RT-qPCR primer sequences. 






COL3 TGGTCAGTCCTATGCGGATAGA CGGATCCTGAGTCACAGACACA 







HAS AGAGCACTGGGACGAAGTGT ATGCACTGAACACACCCAAA 
ELN CTAAATACGGTGCTGCTGGC CATGGGATGGGGTTACAAAG 
α-SMA AGACCCTGTTCCAGCCATC TGCTAGGGCCGTGATCTC 










Figure 5.3. Comparative RT-qPCR analyses of HDFs gene expression after 
culturing on different scaffolds for 14 days. 
Firstly, as shown in Figure 5.3, the incorporation of elastin and hyaluronic acid did not 
cause any significant difference in COL1, COL3, VIM, ELN, and FN gene expression 
compared with COL. The ratio between COL1 and COL3 expressed by HDFs on the COL, 
CE, and CEH scaffold were 2.03 ± 0.14, 2.17 ± 0.18, and 1.98 ± 0.1, respectively. 
Incorporation of elastin resulted in significant up-regulation of αSMA of the HDFs cultured 
on CE or CEH scaffold, compared to COL. HDFs cultured on the CEH scaffold showed 
154 
 
significant upregulation of CD44 and HAS2, compared to COL and CE, attributable to the 
inclusion of hyaluronic acid.  
 
Figure 5.4. Immunofluorescent staining of αSMA produced by HDFs 
cultured on COL, CE, and CEH scaffolds for 14 days. Cell nuclei were 
stained with DAPI in blue. Cytoskeletons were stained with Alex-488 
Phalloidin in green. α-Smooth muscle actins were stained with anti-α-Smooth 
muscle actin antibody (red). 
αSMA staining was conducted on the COL, CE, and CEH scaffold. As shown in Figure 
5.4, αSMA expression was noticed on all samples. Especially, more αSMA expression on 
the CE and CEH scaffold than the COL group were noticed. The overall averaged (n=3) 
αSMA fluorescence intensity on the CE or CEH was similar. This is in accordance with 
the RT-PCR results. αSMA is commonly used as a marker of myofibroblasts formation. 




5.3.3 Immunohistochemistry staining of HDFs differentiation and new ECM 
secretion 
By far, previously described results confirmed the superiority of the CEH scaffold in terms 
of mechanical property, water uptake ability, and the highest expression of αSMA, CD44, 
HAS. From now on, the CEH scaffold was selected for further characterization. As such, 
the cell-laden CEH constructs were selected for IHC study of new ECM production, 
including collagen I, collagen III, fibronectin, and elastin. The cytoskeletons of cultured 
HDFs were stained using Alexa-488 to show the relationship of orientation between ECM 
fibers and HDFs. The staining results (Figure 5.5) confirmed abundant collagen I&III, 
fibronectin, and elastin secretion by the HDFs cultured on the CEH scaffold.  
 
Figure 5.5. Immunofluorescent staining of new ECM secretion by HDFs 
cultured on the CEH scaffold (day 14). Cell nuclei, cytoskeleton, and newly 
secreted ECM were stained with DAPI (blue), Alex-488 Phalloidin (green), 
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and antibodies (red) against human type I, III collagen, fibronectin, and 
elastin, respectively. 
5.3.4 HaCaT cell culture and differentiation 
Immortalized human keratinocytes (HaCaTs) were used in this study to evaluate the ability 
of the CEH scaffold in supporting epidermis regeneration. HaCaT cell viability and 
proliferation behavior were evaluated using live/dead assay and immunofluorescent 
staining of Ki67, a nuclear proliferation marker (Figure 5.6). After culturing on the CEH 
scaffold for 7 days, the HaCaTs cells were alive, indicating good cell viability and the 
inherent biocompatibility of the CEH scaffold. The expression of Ki67 by the HaCaTs also 
confirmed the ability of this CEH scaffold in supporting keratinocytes proliferation. 
 
Figure 5.6. Viability and proliferation of HaCaT cells cultured on the surface 
of the CEH scafold after 7 days. Representative live/dead fluorescence 
images of HaCaT cells on CEH surface with green and red fluorescent 
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indicate alive and dead cells respectively, HaCaT cells expressed cell 
proliferation marker Ki67. 
To assess the differentiation of HaCaT cells on the CEH scaffold, HaCaTs of passage 9 
were seeded on the scaffold and cultured at the air-liquid-interface (ALI) for up to 14 days. 
The resulted epidermis (Figure 5.7) thickness of day 3, day 7 and day 14 were 9.4 ± 2.8 
μm, 36.5 ± 4.3 μm and 78.4 ± 6.3 μm (n = 3), respectively. The thickness of day 14 was 
significantly better than elsewhere reported regenerated epidermis which was about 20 um 
[21]. The H & E stained micrographs (Figure 5.7 day14) clearly showed the stratification 
and flattening of the HaCaT cells cultivated on the CEH scaffold following ALI culture for 
2 weeks. The keratinocytes on top of the reconstructed epidermis demonstrated flattened 




Figure 5.7. Representative images of H&E stained sections of reconstructed 
epidermis on the CEH scaffold after 3, 7, and 14 days culture at the air-liquid 
interface (ALI). Stratification and flattening of HaCaT cells in the 
reconstructed epidermis on the CEH scaffold after 14 days culture can be seen 
clearly. 
The expression of differentiation and proliferation markers by the HaCaTs after 7 or 14 
days’ culture were demonstrated in Figure 5.8, including Ki67 (cell proliferation marker), 
keratin 10 (K10, an early differentiation marker), involucrin and loricrin (terminal 
differentiation markers), and E-cadherin (a cell-junction protein). This suggested that the 
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CEH scaffold were able to support keratinocytes differentiation and epidermal 
reconstruction.  
 
Figure 5.8. Expression of proteins of reconstructed epidermis on the CEH 
scaffold: involucrin & loricrin (green, late differentiation marker), K10 
(green, early differentiation marker), E-cadherin (a cell-junction protein), Ki-
67 (red, proliferation marker), and DAPI (blue, nuclei) stained sections of the 
reconstructed epidermis. 
5.3.5 Organotypic co-culture of HDFs and HaCaTs on the CEH scaffold 
In the final stage of this work, the co-culture of HDFs and HaCaTs was performed. After 
4 weeks’ culture at the ALI, as shown in Figure 5.9, the H&E staining results clearly 
showed the formation of stratified epidermal and dermal layers. In our observation, the 
stratified epidermal/dermal skin tissue was stabilized for at least 4 weeks with minimal 




Figure 5.9. H&E staining of co-cultured  HDFs and HaCaTs after 4 weeks. 
The capability of the dermal layer fibroblasts to produce type I collagen in the 
reconstructed full skin was also evaluated on day 28 (Figure 5.10). The immunofluorescent 
staining results of collagen I (green) that can only be produced by HDFs in the dermis in 
this system, and all cell nuclei (blue), indicate that the CEH scaffold could lead to dermal 
ECM secretion. Cell-cell adherent marker E-cadherin, and epidermis terminal 
differentiation markers (involucrin and loricrin) were all noticed on the reconstructed 
epidermal/dermal skin tissue. This further demonstrated the formation of the structured 






Figure 5.10. Immunostaining of E-cadherin, collagen I, loricrin, involucrin 






Fibroblasts play a vital role in normal wound healing. The behavior of fibroblasts, 
including viability, morphology, proliferation, protein secretion, and gene expression, are 
of critical importance for successful tissue regeneration [28]. In this research, the gene 
expression level of HDFs seeded on different scaffolds were evaluated. The results showed 
firstly that the incorporation of elastin or hyaluronic acid into the collagen scaffold did not 
cause any significant change in new ECM deposition. However, it is worth noting that the 
ratio of collagen I : III on all these scaffolds were roughly 2:1, which implied the cultured 
tissue in this research are more like healthy skin tissues, rather than scar tissues.  
In dermis skin, most of the fibrils are made up of type I and type III collagens. Type I 
collagen is densely packed fibrils that determine the stiffness of the skin. Whereas, type III 
collagen forms randomly dispersed thin collagen fibrils associated with the flexibility and 
plasticity of tissues . [33]. The ratio and crosslinking level between collagen I and collagen 
III determine the strength and stability of both healthy skin tissue and the scar tissue. In 
normal skin, the ratio between collagen I and III ranging from 2:1 to 4:1 according to 
different ages or stages of wound healing [33, 34]. Studies of dynamic wound healing 
process have shown that early granulation tissue has a rather low collagen I : III ratio [35], 
yet in mature scar tissues, the collagen I:III ratio are quite high [33]. For example, the 
collagen I: III ratio in normal scar, hypertrophic scar and keloid scar are 6:1, 6:1, and 17:1 
[36], respectively. In this research, the collagen I: III ratio by HDFs cultured on three 
different collagen-based scaffolds were roughly 2:1. This implied the intrinsic biomimicry 
and skin growth supporting property of these electrocompacted collagen-based scaffolds.  
Besides, the HDFs cultured on the CEH scaffold showed upregulated expression of αSMA, 
CD44, and HAS2 compared to those cultured on COL or CE. The upregulation of αSMA 
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might be ascribed to the incorporation of elastin. Incorporating elastin into collagen 
bundles was reported to induce contractile phenotype in smooth muscle cells [24, 27]. Our 
result is also consistent with previous reports that elastin is involved in preserving a 
contractile phenotype both in vitro [37] and in vivo [38]. Normal wound healing is 
composed of three phases: inflammation, proliferation, and remodeling [39]. Both 
fibroblasts and myofibroblasts play a pivotal role in wound healing. Phenotypically, 
myofibroblasts are an intermediate cell type between fibroblasts and smooth muscle cells 
(SMCs) [39]. When skin tissue is damaged, fibroblasts will be activated and differentiate 
into myofibroblasts. Myofibroblasts then become active during the proliferation phase of 
wound healing, and gradually disappear in the remodeling stage [39]. Myofibroblasts could 
generate large contractile forces and actively produce extracellular matrix (ECM) proteins 
to promote wound closure. Nevertheless, excessive force and over-production of ECM, 
however, are also the major cause of scar formation. Thus, the issue of how to maintain a 
balance between fibroblasts and myofibroblasts remains a challenge for further 
investigation.  
Another possible contributing factor for the up-regulation of αSMA might be the 
incorporation of HA and the matrix mechanical properties. The transformation and 
maintenance of the myofibroblast phenotype are mediated by HA through a TGF-β1– 
dependent steps [40]. Recent work has revealed that the rigidity of the ECM has significant 
effects in fibroblast function [41], including apoptosis signaling, differentiation into 
myofibroblasts [42], and matrix metalloproteinase (MMP) activity [43].  
Inclusion of HA also resulted in the upregulation of CD44 and HAS2 in the HDFs cultured 
on the CEH scaffold, compared to the COL and CE scaffold.  CD44 is the predominant 
cell surface receptor for HA binding [44]. HA and CD44 are abundant in the extracellular 
spaces between keratinocytes throughout the epidermis. CD44 receptors were reported to 
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be responsible for regulating keratinocyte proliferation in response to extracellular stimuli 
[45]. Also, many of the functions of HA in wound healing are performed in conjunction 
with or while HA is bound to CD44 [44]. In the final re-epitheliazation stage of wound 
healing, the complex composed of HA and CD44 regulates keratinocyte migration and 
proliferation, and maintains local HA homeostasis [46].  
By far, we have demonstrated the superiority of the CEH scaffold, including the 
mechanical property, swelling ratio, stimulating HDFs proliferation, inducing αSMA, 
CD44, and HAS2 expression, in comparison with the COL and CE scaffold. We further 
demonstrated the ability of this CEH scaffold in supporting new ECM deposition, 
including collagen I, collagen III, fibronectin, and elastin. In skin tissues, collagen, elastin 
and fibronectin are the main components of ECM. With collagen acting as the most 
prevalent fiber-forming protein and comprising about 70% of the dry weight of human 
skin, elastin helps define the skin tissue rigidity and elasticity, and fibronectin is one of the 
key mediators in hemostasis and cell migration in the wound healing [28]. Especially in 
the proliferative phase of wound healing, fibroblasts are attracted to the wound site to 
synthesize granulation tissue to fill the wound site and allow ingrowth of new blood vessels 
[36]. The invasion of fibroblasts into the granulation tissue is dependent on the complex 
formed by HA and fibronectin [47]. Thus, the fact that HDFs could produce these important 
ECM components highlight the potential of CEH as dermal scaffolds. 
Then, the ability of the CEH scaffold in supporting HaCaTs cell function and epidermis 
regeneration were further demonstrated. Especially, on the regenerated dermis, important 
HaCaTs differentiation markers were noticed, including K10 (early differentiation 
marker), E-cadherin, and involucrin, and loricrin. E-cadherin is one of the most abundant 
molecules in cell-cell adhesion in epithelial tissues[48]. The presence of cell-cell junction 
protein E-cadherin, demonstrated the formation of a confluent cell monolayer after being 
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cultured at ALI for 7 days. The formation of this confluent monolayer is of significant 
importance for subsequent homogeneous epidermal stratification and retain of the 
properties of intact epidermis [21]. As uneven keratinocyte patchy formation may result in 
immature keratinocyte differentiation. A non-uniform stratified epidermal layer might 
easily peel off [21].  
Involucrin and loricrin are terminal differentiation markers expressed by keratinocytes 
[49].  The involucrin appears earlier than loricrin, and both of them are precursors of the 
cornified cell envelope. Involucrin, loricrin, together with keratin, filaggrin, and small 
proline rich proteins (SPRs), form a specialized cornified cell envelope structure [50]. This 
structure, together with the functional tight junctions and stratified architecture of confluent 
keratinocyte, help rebuild the mechanical and permeability barrier of epidermis [51]. 
Therefore, the expression of early differentiation marker K10, terminal differentiation 
makers including involucrin and loricrin, and adherens junctions’ marker E-cadherin, 
confirmed the superior ability of this CEH scaffold in supporting epidermis differentiation 
and stratification. Furthermore, in the organotypic co-culture of HDFs and HaCaTs, the 
formation of a double-layered high stratified skin structure further highlighted the potential 
of this CEH scaffold in supporting full-thickness skin regeneration.  
Further detailed in vitro and in vivo studies will be required to better elucidate the matrix-
cell interactions and improve the performance of the biomimicry scaffolds in skin repair 
and regeneration. The double-layered cellular constructs could be employed as a model to 
investigate vascularization and nerve innervation. This could be done through co-culture 
with relevant cell types, such as human umbilical vein endothelial cells and neural stem 
cells, for example, in combination of related growth factors that can be co-





In this study, an ECM-like dermal scaffold composed of collagen, elastin, and hyaluronic 
acid were fabricated to support epidermis/ dermis skin tissue regeneration. The current 
work demonstrated that incorporation of elastin into the COL membrane induced the 
contractile phenotype in myofibroblasts. HA incorporation promoted upregulation of 
HAS2 and CD44, which is vital for new ECM synthesis and fibroblast function. Further, 
the ECM components-specific microenvironment provided by our ECM-like CEH scaffold 
encouraged dermal-like ECM secretions, epidermis differentiation, and formation of 
stratified epidermal-dermal structure. Overall, the outcome of this study provided 
significant insight into the selection of dermal scaffold components or bio-ink towards 
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The work presented in this thesis aimed to fabricate scaffolds for skin regeneration and 
wound healing applications. The key principle of this scaffold fabrication is to mimic the 
components and structure of natural skin ECM. As such, the materials used in this research 
are natural ECM components, including collagen, elastin, GAGs (hyaluronic acid), and 
GAG like marine polysaccharides: ulvan. The fabrication technique utilized here is 
electrocompaction. This produces densely packed, highly ordered collagen scaffolds that 
resemble the microstructure of natural ECM. The work described in the thesis is the first 
example of the using electrocompaction in skin regeneration and wound healing. 
To mimic the function of natural skin ECM, the most straight forward and promising way 
is to utilize naturally occurred ECM components as the main material to fabricate scaffolds. 
In Chapter 1, roles of natural ECM components, including collagen, elastin, and GAGs, 
were reviewed and explained. Traditional and advanced fabrication methods for skin 
scaffolds were also reviewed. It is important to notice, even though the method of 
electrocompaction was explored in various areas, such as tendon repair, cartilage 
regeneration, even living machines. No work has been done to apply this method for skin 
regeneration which highlighted the importance of this research.  
Chapter 2 outlined main experiments conducted in this research.  
In chapter 3, the method of electrocompaction was applied for the first time in skin 
regeneration. Densely packed, highly ordered collagen sheets with a microstructure similar 
to that of natural skin ECM were fabricated using the method of electrocompaction. To 
mimic the major structure in natural skin tissue more closely, a GAG-like material-ulvan 
was coated onto this ECL scaffold. Physiochemical and biological characterization 
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demonstrated the feasibility of this method in fabricating skin scaffold, and showed the 
growth-supporting function of this scaffold to HDFs cells. 
In chapter 4, a more biomimicry skin scaffold composed of naturally occurred skin ECM 
components, including collagen, elastin, and hyaluronic, were fabricated. One of the 
obstacles in this part was to incorporate these three types of molecule into the membrane 
uniformly. Naturally, due to similar properties, collagen and elastin are electrocompactable. 
However, HA was not electrocompactable. Thus, two fabrication procedures were 
conducted. One way is to do HA amination firstly and then co-electrocompact collagen, 
elastin, and HA. Another way is to co-electrocompact collagen and elastin, then couple HA 
into the collagen/elastin scaffolds. The second way was finally choose for later applications 
due to convenience and simplicity. A trail application of using electrocompacted collagen  
thread for nerve repair was also explored in this chapter. 
In chapter 5, the ability of such a collagen/elastin/hyaluronic acid (CEH) scaffold in 
supporting dermis, epidermis, and full skin regeneration was investigated and 
demonstrated. The results confirmed its superior ability in supporting HDFs proliferation, 
inducing HDFs differentiation into myofibroblast, new ECM deposition in dermis. 
Epidermis regeneration supporting was also confirmed in terms of HaCaTs growth, 
stratification, and differentiation. After the organotypic co-culture of HDFs and HaCaTs 
on the CEH scaffold, a two-layered dermal/epidermal structure was also reconstructed. All 
these results demonstrated the superior potential of this CEH scaffold in the application of 
skin regeneration and wound healing. 
In conclusion, in this research, the ECM component-based scaffolds were fabricated and 
evaluated for skin regeneration. The unique property of such scaffolds are densely packed, 
highly ordered collagen bundles that can mimic the intrinsic structural and compositional 
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property of natural skin ECM. By integrating the ECM cue, the ECM-like CEH scaffold 
demonstrated its superior ability in supporting skin cell function and skin regeneration. 
While further research will be necessary, current findings of this research demonstrate the 
superior ability of such scaffolds in supporting dermis, epidermis, and full skin 
regeneration. The proposed study will provide a strong base for further advancing 




6.2 Future work 
With the ability of the CEH scaffold in supporting skin regeneration being proved, further 
detailed in vitro and in vivo studies will still be required to better elucidate the scaffold-
cell interactions. More work could be done to improve the performance of the biomimicry 
scaffolds in skin repair and regeneration.  
Incorporation of growth factors into the scaffold represents another promising area to 
explore [1]. Growth factors are critical extracellular cues during the wound healing process 
[2]. Supplements of exogenous growth factors hold tremendous potentials to induce faster 
re-epithelialization and wound healing process. Essential growth factors involved in the 
wound healing process include platelet-derived growth factor (PDGF) [3], epidermal 
growth factor (EGF) [4], transforming growth factor - β [5], heparin-binding EGF-like 
growth factor and so on. Incorporating growth factors into the collagen-based scaffolds 
through co-electrocompaction should result in more advanced physiochemical and 
biological performances. By achieving an appropriate release profile, this will be of great 
interest in terms of the bioengineering of biomimetic and functional skin scaffolds.  
The skin is a highly complicated and sensitive organ [6]. It is densely innervated with 
different structures, such as hair follicles, nerves, blood vessels, and melanin. These 
structures enabled various skin functions such as barrier function, perceptions, nutrients 
transportation [7]. For successful wound healing, it is of crucial importance that 
angiogenesis and nerve regeneration processes take place [8]. Tissue engineered skin with 
improved nerve regeneration property by the incorporation of Schwann cells was 
constructed [7]. A 3D pre-vascularized skin patch pre-loaded endothelial progenitor cells 
(EPCs) and adipose stem cells (ASCs) was reported to stimulate wound closure and induce 
vascular regeneration [9]. As such, the double-layered cellular constructs built in this 
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research could be employed as a model to investigate vascularization and nerve innervation. 
This could be done through co-culture with relevant cell types, such as human umbilical 
vein endothelial cells and neural stem cells. 
An in vivo cutaneous wound healing model on immunodeficient mice could also be 
considered. Especially, as reported by Cubo et, al [10], a skin-humanized mice model was 
utilized to analysis the in vivo maturation and differentiation of a 3D printed skin patch. 
Such model were reported to be an excellent system to perform in vivo human skin 
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